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Skeletal remains are often submitted for DNA analysis for human identification 
(HID) purposes, to either supplement or substitute other forensic identification methods, 
such as anthropological and odontological analyses. However, the identification of skeletal 
samples via DNA testing is often challenging and alternate sample processing methods 
may offer some effective solutions. Current protocols for processing skeletal material 
involve crushing the bone into a fine powder, which requires specialized equipment, 
reagents, training, and can pose an increased risk of contamination. Although methods that 
involve powdering bone tissues for extraction often yield sufficient results for statistical 
comparisons, bypassing this step can eliminate many of these risks, save time and 
resources, and also make bone extractions easier for forensic DNA laboratories to 
implement.  Several issues, such as PCR inhibition and DNA degradation, can also make 
identification more difficult. Therefore, products that provide analysts with more 
information about sample quality at various stages of the HID process could greatly 
improve the genotyping process and assist with sample triage and workflow decisions.   
The main aim of this research was to evaluate the effectiveness of various protocols 
that eliminate the need to powder bone tissue prior to DNA extraction. A secondary aim of 
this study was to investigate the benefits of internal STR quality controls for assessing 
sample quality and determining rework strategies when challenging samples fail to produce 
complete STR profiles. Several non-powdering DNA extraction methods were tested with 
human skeletonized remains of varying quality to identify the most efficient protocol to 
 
vi 
achieve the highest genotyping success. In addition, a broader scope of forensically 
relevant sample types were genotyped with the Investigator® 24plex QS and GO! kits that 
include quality controls to test their effectiveness in identifying issues that negatively 
impact STR success, and guide the most efficient sample rework strategies.   
As a result of this work, an effective powder-free DNA extraction workflow was 
identified and shown to be successful with a variety of environmentally challenged skeletal 
samples. Additionally, we have demonstrated that internal STR quality sensors can 
simplify STR profile interpretation, help reduce the number of sample reworks, and 
generate more complete STR profiles when samples are reworked based on the information 
provided by the quality sensors. These alternate methodological approaches can reduce 
overall processing time and costs for a wide range of challenging samples subjected to STR 
typing for human identification purposes. This research has also been used as the scientific 
basis to amend recommended protocols for some commercial HID products, which will 
directly benefit the forensic community. 
 
KEY WORDS:  Forensic science, Forensic biology, DNA, Bone, Skeletal, Human 
identification, Low-template DNA, LCN, Short tandem repeats, Automation, Challenging 
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Decomposed or skeletonized human remains may be identified using fingerprint 
analyses or dental record comparisons, but when these strategies cannot be used, DNA 
analysis is relied upon for identification (1-3). DNA isolated from biological material can 
be used for paternity testing, human identification (HID), and forensic investigations (3), 
with short tandem repeats (STRs) being the current gold standard for human identification 
(4-7). Buccal swabs and blood specimens are common sources of abundant nuclear DNA 
for forensic analysis (3, 8) and provide robust and reliable genotyping of individuals with 
high discriminatory power (8). However, some biological samples submitted to forensic 
laboratories prove to be more challenging for DNA extraction and analysis. Biological 
evidence recovered from crime scenes can be degraded and/or in trace amounts, with 
potential contamination and/or polymerase chain reaction (PCR) inhibitors due to 
environmental conditions or the samples themselves (9). In the case of mass disasters, 
missing persons’ cases, severe fires, and mass graves, skeletonized remains (bone and 
teeth) may be the only elements available for human identification (3, 4, 9-12).  
Mass Disasters and Missing Persons 
Mass Disasters  
Mass disasters are sudden and catastrophic events that result in the death or injury 
of many people (3, 13-15). They can be natural (epidemics, severe weather events), 
accidental (industrial, vehicular), or terroristic acts (chemical, biological, or radiological 
warfare, explosions) (3, 13-15). Notable mass disasters of the early 21st century include 




Indian Ocean/Southeast Asian earthquake and tsunami in 2004 (2, 3, 13, 16), Hurricane 
Katrina in 2005, and the Haiti earthquake in 2010, among many others (13).  
The process of identifying human remains resulting from a mass disaster is 
commonly referred to as Disaster Victim Identification, or DVI. There are two main 
objectives of DVI: 1) identifying recovered remains, and 2) associating fragmented 
remains to each other (14). The first function is necessary for both familial closure during 
the grieving process as well as criminal/civil investigations (3, 13). Re-association of 
remains to each other is necessary when the remains are highly fragmented, such as those 
recovered from the 9/11 World Trade Center attacks (3), or co-mingled, such as remains 
exhumed from mass graves. The identification process consists of comparing and matching 
ante- and post-mortem samples, such as fingerprints, dental records, unique personal or 
medical items (e.g. medical implants with serial numbers), and/or through direct DNA 
matching with personal items belong to the victim, or kinship analysis (3, 13, 15). As there 
are a variety of methods with which victims may be identified, DVI is a multi-disciplinary 
exercise and generally involve the following disciplines: forensic anthropology, 
fingerprinting, forensic odontology, radiology, forensic DNA/biology, and forensic 
pathology/medical examiners (13, 14). In the United States, DVI teams of experts include 
the Disaster Mortuary Operational Response Team (DMORT), the FBI’s Evidence 
Response Team (ERT), and the Office of Armed Forces Medical Examiner (OAFME) (13). 
An interdisciplinary approach is vital as multiple modes of identification help strengthen 
the confidence of matches (14) and in many instances, some of the more traditional 




According to Montelius and Lindbolm, the identification process with DNA 
includes five main steps: 1) collecting the best ante-mortem samples (e.g. 1st degree 
relatives, archived blood/biopsy samples from potential victim, personal objects from 
deceased); 2) choosing the most optimal post-mortem samples that are in the best 
condition; 3) DNA analysis, matching ante- and post-mortem data, and calculating match 
statistics; 4) prioritizing quality throughout the process; and 5) cooperation between DVI 
disciplines (16).  
Although DNA is frequently used for DVI and technology and processes have 
improved over time, it still has limitations. Primarily, DNA testing and identification is 
dependent on suitable reference samples for comparison (3). For example, without direct 
ante-mortem references, same-sex siblings cannot be distinguished based on parental DNA 
profiles alone (14). Also, when multiple family members are involved and in the absence 
of anthropological data, partial profiles make it difficult to fully identify someone within a 
family without an ante-mortem reference sample, especially when comingling has occurred 
(14, 16). During the initial recovery phases after mass disasters occur, storage facilities 
may not be available or adequate enough to slow decomposition at low temperatures (room 
temperature storage and preservation needed) (3).  In contrast to the highly damaged and 
fragmented remains recovered from the 9/11 attacks, the victims recovered from the 
December 2004 Indian Ocean Tsunami had little fragmentation but high 
putrefaction/decomposition (3). This disaster was responsible for the most abrupt death toll 
in history with over 200,000 people deaths across 10+ countries (3, 13) and resulted in 




Current DVI standards are based off Interpol and International Society of Forensic 
Genetics (ISFG) guidelines (16); however, laws regarding DVI processes are ultimately 
governed by the country of incidence (14). The cross-training of experts such as forensic 
geneticists, anthropologists, and pathologists is recommended and ideal (14, 17) as 
consultation with a geneticist during sample collection can guide the pathologist in 
choosing the proper tissue type based on the state of preservation, and anthropological 
landmarks should be avoided when cutting bone samples (14). Anthropologists and/or 
pathologists can also screen and remove non-human remains, which reduces the amount of 
unnecessary testing performed (14, 17). The preferred sample types for remains are buccal 
swabs, blood, and deep muscle/soft tissues, but when high decomposition or other insults 
prevent use of these, bone and teeth are the last resort (3, 13). Although bone and teeth 
typically have better results than soft tissue when remains are highly decomposed, the 
sample processing is long and laborious, with steps including de-fleshing (if applicable), 
cleaning, drying, cutting, drying, powdering, and decalcification (3). Nevertheless, it is 
recommended to collect and store as many sample types to avoid re-sampling 
retrospectively (14). As for genotyping, multiplex STRs are still the preferred DVI DNA 
technology (13, 14), but the main challenge of successfully genotyping highly degraded 
DNA has led to the development and implementation of alternate technologies, such as 
mini-STRs (7, 13, 18), mitochondrial DNA (7, 17, 19-22), or SNPs (14, 23-26). 
Missing Persons 
In addition to those lost during mass disasters, individuals may be separated from 
their families and loved ones as a result of political conflicts (e.g. wars), mental illness, 




immigration and seeking asylum in another country. According to the National Missing 
and Unidentified Persons System (NamUs), over 600,000 people go missing each year in 
the United States alone (27). Additionally, an estimated 4,000+ unidentified remains will 
be recovered annually with approximately 25% of those not being identified after a period 
of one year (27). Currently, there are over 13,000 open cases for unidentified remains and 
16,700+ open cases for missing persons across the United States and its surrounding 
territories (28). NamUs is a federally funded program that offers a database platform and 
several forensic services, such as fingerprints, DNA analysis, forensic odontology, and 
forensic anthropology, at no cost to law enforcement, other agencies, and the public in an 
effort to help clear missing and unidentified persons cases across the country (27).  
The Armed Forces DNA Identification Laboratory (AFDIL) within the Armed 
Forces Medical Examiner System (AFMES) in Dover, Delaware is responsible for 
processing and identifying US military and civilian remains from current and past conflicts 
(29), such as World War I&II, Vietnam War, the Battle of the Punchbowl (Korean War), 
Pearl Harbor, Gulf War, and other recent wars in the Middle East (17, 29). For the past 
conflict remains specifically, AFDIL collaborates with, and provides testing services for, 
the Defense POW/MIA Accounting Agency (DPAA) (17, 29). This partnership aided in 
the identification of over 200 US military remains in 2017 and approximately 160 the 
previous year (30). To help their identification efforts, the Armed Forces Repository of 
Specimen Samples of the Identification of Remains (AFRSSIR) was established in the 
early 1990’s to collect and maintain DNA reference samples (blood cards) for all service 




having direct references has allowed for faster and more definitive identifications when 
other methods (dental and fingerprint comparisons) could not be used (31). 
Outside of the United States, international organizations such as Interpol and the 
International Commission on Missing Persons (ICMP) are also tasked with the goal of 
finding and identifying missing persons. Initially established in 1996 with the objective of 
identifying missing persons’ remains from the 1990’s Yugoslavian conflicts, the ICMP’s 
mandate has been expanded globally as a result of its success (32). Over the past two 
decades, ICMP has influenced legislature, cooperation between governments, and the 
development and implementation of forensic practices across 40+ countries including 
Kosovo, Western Balkans, Iraq, and Bosnia and Herzegovnia (32). Additionally, the 
Commission has processed over 70,000 post-mortem samples with over 27,000 unique 
profiles being generated (32). 
Challenging Samples 
Decomposed Tissues 
In general, soft tissues are sources of abundant DNA, simple to collect, and quick 
and easy to process (2). However, when the tissues begin to decompose, the integrity of 
the DNA rapidly declines which makes identification via DNA testing difficult (2, 3). The 
rate of decomposition can be affected by many factors, including temperature, humidity, 
trauma, disposal conditions, as well as insect, animal, and microbial activity (1, 3, 4, 33, 
34). A study by Schwark in 2010 compared the STR success rates between various 
putrefied soft tissues (2). Samples from the aorta, kidney, liver, and skeletal muscle were 
collected from 18 human remains in various stages of decomposition (PMI of several days 




as expected, and skeletal muscle yielded significantly lower amounts of DNA compared to 
the other three tissue types (2). STR typing results showed that DNA extracted from the 
aorta and kidney consistently generated the most complete profiles (2). These results 
supported other studies that suggested aorta tissue was useful for the identification of 
decomposed remains (35, 36). Other studies have used brain cortex (37, 38), lymph nodes 
(37), skin (39, 40), muscles (37, 39-41), organs (37, 42), and prostate/uterus tissues from 
decomposed remains (38), with varying success. Although DNA is more stable in hard 
tissues (bone and teeth), they are generally only used when soft tissues are not available or 
yield no useable DNA since the DNA extraction methods are lengthy and laborious (2, 3, 
14).  
Skeletonized Remains 
Over the past 15 years, several studies have investigated which bony elements in 
the human body may provide the best DNA yields and most successful genotyping results 
for identification purposes (4, 17, 43-45). The highest DNA yields and STR success rates 
have been reported in bone samples taken from femur and teeth (~82-87%) due to the dense 
cortical bone of weight-bearing leg bones and the protective enamel coating on teeth (4). 
In 2007, Milos et al. ranked bones based on their STR success, with the top five being: 
femur, teeth, tibia, fibula, and vertebra (4). With the exception of the fibula, STR success 
positively correlated with Galloway et al.’s ranking of long bones based on decreasing 
density (femur, tibia, humerus, radius, ulna, and fibula) (46). As a general trend, Milos 
observed that lower limb long bones yielded consistently higher success rates compared to 




While these studies and many others have shown that femurs and other cortical 
bones may give the highest DNA yields, most of these studies do not include smaller, 
cancellous bones and other atypical bones (i.e. tarsal bones and phalanges) (17, 44). In a 
2014 study, the first distal phalynx of the hand, second cuneiform, and maxillary molar 
tooth ranked the highest with a DNA yield per mass of sample above 420 ng/g bone while 
the femur ranked #49 (out of 55) with only 25 ng/g bone (44). When categorized by region, 
teeth ranked the highest in terms of DNA yield followed by cancellous bones in the foot 
and hand, with the leg being ranked #5 (out of 7) (44). A synchrotron radiation micro-CT 
scan was performed on the cancellous bones from that 2014 study, which showed potential 
soft tissue remnants within the marrow spaces that were not visible to the naked eye, which 
could have accounted for the higher DNA yields in these cancellous bones (43). Finally, a 
comprehensive study in 2019 showed that element success varied largely depending on the 
DNA extraction method used, yet weight-bearing long bones usually ranked higher than 
other parts of the skeleton (17), which is consistent with many other studies (4, 20, 44-49). 
Metacarpals and metatarsals showed a variable high success rate; however, they were 
consistently effective for mitochondrial sequencing (17). In general, smaller elements may 
be useful for when mostly intact skeletonized remains are recovered; however, additional 
skeletal elements would likely need to be genotyped when partial or fragmented remains 
are recovered and long bones may be necessary for the sorting and re-association of 
fragmented remains (17).  
Environmentally Challenged Samples 
Exposure of biological samples to extreme environmental conditions such as heat, 




able to be recovered, thereby making traditional STR typing and analyses difficult (1). 
Other insults that damage DNA include exposure to ultra-violet (UV) radiation, fire 
exposure, and submersion in water (50). The effects of fire on human bodies are strongly 
reliant on the level of heat and the duration of the fire (51, 52). Nevertheless, DNA has still 
been recovered from a variety of burned remains for identification purposes (53-58). 
The quality and quantity of DNA recovered from submerged remains are heavily 
influenced by factors such as the type of water (saltwater vs freshwater), depth, and length 
of time submerged (1, 59). For example, for a case where remains were found after being 
at the bottom of the ocean for ~11 years, a complete STR profile was recovered (1). The 
lack of exposure to light, alkalinity (pH around 7.5-8.5), and low temperature of the water 
was believed to preserve the DNA (1). In contrast, remains that were found near a river 
dam after 3 years generated only a partial DNA profile (59). Other factors that can 
complicate the identification of submerged remains are post-mortem animal predation, 
tissue putrefaction and decomposition, and drifting/dragging of remains along the ocean 
floor (1). 
Common Forensic DNA Issues and Solutions 
When performing STR analyses from bone and other challenging samples, several 
difficulties may arise due to DNA damage, fragmentation, very low amounts of DNA 
available for amplification, DNA contamination, and/or inhibition. These conditions may 
result in the loss of loci and increase of undesired PCR artifacts due to stochastic effects 
during amplification (60-63). These artifacts must be taken into consideration when 






Multiple studies have reported reduced STR success due to: an increase in post-
mortem interval (2, 4, 44), environmental damage (exposure to: increased temperatures, 
UV radiation, humidity, insects, animals, and microbes) (1, 4, 16, 20, 33, 34, 64), disposal 
conditions (buried in soil, partial/complete immersion in water, burning, or wrapping in 
plastic) (1, 4, 20, 33), and chemical damage (mortuary treatments such as embalming) (16, 
19, 64). Nucleases such as DNase enzymatically cleave DNA into shorter fragments (65, 
66) by hydrolyzing phosphodiester bonds, and are released endogenously from the cell or 
introduced exogenously from microbes or invertebrates in the surrounding environment 
(66, 67). The initial digestion of chromatin is facilitated by proteases following cell death, 
with DNA becoming susceptible to further digestion/fragmentation (66).  
DNA can also be degraded spontaneously via non-enzymatic processes, such as 
through oxidation and hydrolysis; however, this happens at a much slower rate (66). 
Environmental damage due to high temperatures and humidity lead to strand breakage and 
base modifications, while chemical damage results in base transitions due to deamination 
(19, 64, 67). Crosslinking of DNA can occur either between DNA and proteins or between 
two DNA strands of the same helix (66, 67), the latter of which is temperature dependent 
(66).  
Soil has been reported to affect DNA degradation and genotyping success (33, 68-
70). Factors that influence the DNA degradation rates of biological samples recovered from 
soil include the presence and concentration of bacterial DNases, pH levels, moisture, and 
mineral content (33). Soils that have a higher humidity level generally have more 




microbes have nuclease enzymes (66). Additionally, warmer temperatures tend to increase 
DNase activity, greatly decreasing DNA quantity and quality (33). With this knowledge, it 
is not surprising that marshy soil has been shown to be more detrimental than sandy soil as 
it has a higher moisture content and consequently, microbial activity (33) and that 
depending on the conditions, buried samples may have a higher rate of DNA loss than 
surface-exposed samples (20, 70). 
These forms of DNA damage may decrease the success of downstream PCR and 
quality of STR profiles. There are three main effects degradation can have on the 
amplification process: amplification failure, preferential amplification, and miscoding 
lesions (due to base modifications) (66). Current STR multiplexes include amplicons 
ranging from 60-450 basepairs (bp), but degraded DNA is often cleaved into smaller 
fragments (approximately <250 bp) (67), resulting in a reduced success of longer loci 
amplification (loci dropout) compared to smaller amplicons (66). Allelic dropout occurs 
when one of the allele pairs is preferentially amplified (typically the shorter one), making 
a heterozygote appear to be homozygous (66). Adjusting interpretation guidelines for 
degraded samples, such as generating composite profiles, can help accommodate allele 
drop-out (14). Miscoding lesions affect the amplified sequence by inducing the 
incorporation of the wrong base by the polymerase during extension (66, 67, 71), and if 
this occurs early in amplification, it can propagate throughout the PCR leading to an 
abundance of incorrect sequences (66). However, length-based analyses, such as STRs, are 
generally unaffected by miscoding (66) as long as no bases were inserted or deleted. One 
solution commonly applied to degraded samples is performing multiple amplifications of 




the storage of DNA in cooler temperatures or preservative solutions can overall help slow 
degradation processes by reducing or halting enzymatic activity and preventing further 
DNA damage events (1, 16, 66). 
Low-Template DNA (LT-DNA) 
Samples with low-template DNA are classified as having less than 100 pg DNA 
(66, 72) and/or when the allele calls consistently fall below the stochastic threshold (73). 
Bone samples often contain low amounts of DNA, and depending on the environmental 
conditions to which they were exposed, may also be highly degraded (7, 9). Other 
forensically relevant samples that commonly result in low amounts of DNA being 
recovered are cigarette butts (74, 75), hair (75-77), nails (74, 75), touched items (75, 78), 
weapons and explosives (78-81), and minor contributors in some DNA mixtures (78, 82, 
83). Amplification of LT-DNA samples often results in various stochastic effects during 
PCR such as preferential amplification, allele/locus dropout, allele drop-in, and 
exaggerated stutter. Preferential amplification can result in unbalanced STR profiles, with 
low peak height ratios (PHR) between sister alleles at heterozygous loci (62, 63, 82, 84). 
Allele and/or locus drop-out is commonly observed in STR profiles from samples with low 
amounts of DNA and/or when DNA is highly degraded (60, 62, 63, 84-88). Allele drop-
out can be attributed to extreme preferential amplification of one allele in a heterozygous 
pair, resulting in false homozygotes (63, 82), or both alleles can fail to amplify resulting in 
locus drop-out (63). Allele drop-in can also occur but is also more likely due to sporadic 
contamination (82, 86). Finally, stutter peaks may also be higher than expected 
(exaggerated stutter) (62, 63, 89), making profile interpretation difficult, especially with 




Several approaches are commonly used to improve STR results from LT-DNA 
samples (11, 19, 60, 62, 63, 84, 86-88, 90). These include increasing the Taq polymerase 
concentration (19), splitting the sample and performing multiple amplifications to generate 
a consensus profile (19, 63, 66, 87), nested PCR (63, 66, 90), post-PCR cleanup or 
concentration, and increasing the injection time and voltage during capillary 
electrophoresis (62, 66). However, the most common strategy is to simply increase the 
number of cycles during PCR amplification, a process termed low copy number (LCN) 
typing (11, 19, 60, 62, 66, 84, 86, 87).    
The robustness and reliability of results from LCN typing has been a subject of 
scrutiny in literature being described as unreliable, non-reproducible, and often practiced 
inconsistently or inappropriately (61, 63, 86, 91, 92). However, varying levels of success 
using LCN-typing has been reported (11, 19, 60-63, 84, 86-88). In general, it is agreed that 
PCR artifacts, such as heterozygous peak height imbalance or exaggerated stutter, are often 
more severe (60, 62, 63, 84, 86, 88). Increasing the number of PCR cycles from 28 to 34 
using the AMFlSTR® SGM Plus™ PCR amplification kit enabled Kloosterman and 
Kersbergen to generate full profiles from bone and teeth extracts that had previously 
produced partial or no profiles when amplified with only 28 cycles (84). This six cycle 
increase with the same kit also allowed Gill et al. to generate full profiles from dilutions of 
control DNA as low as 25 pg with a decrease in stutter events, but an increase in stutter 
peak area and heterozygote peak imbalance (63). In another study, serially diluted DNA 
extracts with 100 pg of DNA that were amplified with 32 cycles showed stutter ratios as 




validations need to be performed and the potential benefits must be weighed against any 
issues (technical, analytical, or legal) that may arise. 
Contamination 
Due to the nature of forensic evidence, items submitted for DNA testing can be 
contaminated with exogenous DNA from a variety of sources. Contamination may occur 
during sample collection, transportation from the scene to the laboratory, and/or handling 
processes due to improper personal protective equipment (PPE) and techniques (16, 93). 
DNA contamination can also originate from the collection source itself. For example, the 
comingling of multiple human remains introduces the potential for cross-contamination 
which compromises sample integrity (14).  
Another source of DNA contamination is during the DNA extraction and pre-PCR 
sample handling steps (93). In order to reduce DNA contamination, wearing disposable 
PPE, sound laboratory practices and techniques, frequent cleaning, disposable 
consumables, appropriate storage conditions, and the physical separation of laboratories 
(DNA extraction, PCR set-up, and post-PCR) are all routinely employed (16, 86). 
Furthermore, DNA contamination is monitored within forensic laboratories via the 
inclusion of negative controls at all stages of testing (86), duplication of PCR 
amplifications when possible (14, 86), and comparison of results against staff elimination 
DNA databases (86).  
Despite these measures, increased sensitivity in current STR kits has led to more 
instances of low-level contamination being detected (94). In 2016, the International 
Organization for Standardization developed a new ISO standard, ISO 18385:2016, which 




reagents used in pre-amplification workflows. With the goal of minimizing human 
contamination in these products, “forensic grade” consumables are now being offered by 
forensic manufacturers and used by laboratories.  
PCR Inhibition 
PCR inhibitors are substances that interfere with the DNA amplification process in 
some way, resulting in reduced or no amplification products (65, 69, 95). These agents can 
be organic (e.g. ethanol, humic acid, melanin) or inorganic (e.g. calcium ions) (65), are 
abundant in nature (found in foods, environment, and biological matrices), and can have a 
wide range of inhibitory effects depending on their concentration (65) and other factors. 
Although inhibition has been reported as the most common reason for failed amplifications 
when there is sufficient template DNA present (69), severe inhibition may also be 
misinterpreted as severe degradation in some cases (69, 96, 97). 
PCR inhibitors may originate from the sample itself, its surrounding environment 
(e.g. humic acid in soil), or introduced during sample processing or DNA extraction (65). 
Common endogenous inhibitors that are often released during cell-lysis and co-extracted 
with DNA (69, 95, 98) include: proteinases in milk, polyphenol in foods, calcium ions and 
heavy metals in bones, collagen in tissues, melanin in hair and skin, and hematin in blood 
(48, 65, 69, 98). Inhibitors that may carry over from DNA extraction include: salts (NaCl), 
detergents (sarkosyl or SDS), EDTA, ethanol, isopropanol, phenol, mercaptoethanol, and 
DTT (65).  
There have been several proposed mechanisms for PCR inhibition based on the 
agent (Table 1.1). These generally include the inhibitor binding to the DNA polymerase, 




binding to DNA polymerase cofactors (65, 69, 95). The presence of proteases and 
detergents (e.g. phenol) indirectly result in inhibition by degrading the DNA polymerase, 
while melanin directly inhibits by forming a reversible complex (65). Melanin also binds 
to the DNA molecule itself, inhibiting the DNA polymerase during extension. Although 
larger amplicons are usually preferentially affected by several forms of PCR inhibition, 
this is not always the case (95, 96). For example, studies have demonstrated that regardless 
of their inhibitory mechanism, increasing concentrations of inhibitors, such as calcium, 
collagen, and humic acid, generally had a greater effect on larger amplicons, which visually 
mimics DNA degradation in STR profiles (96, 99). However, for the inhibitors that bind to 
the DNA template (e.g. collagen and humic acid), smaller loci were also observed to be 
affected, with either reduced signal or complete drop out of the allele(s) (96, 99). 
Calcium, collagen, hematin, and tannic acid interact with the DNA polymerase and 
inhibit its activity (65, 95). Humic acid and collagen interacts/binds with DNA, which 
prevents the enzymatic reaction from occurring, especially when the inhibitor binds at 
primer sites (65, 95). Higher primer melting temperatures can help decrease primer 
inhibition as it creates a strong bond with DNA and prevents the inhibitor from binding to 
the template (65, 95). Calcium in high concentrations competes with magnesium to bind 
with the DNA polymerase while tannic acid and EDTA chelate magnesium, depleting its 
availability during amplification (65). However, both result in a reduction of enzymatic 







TABLE 1.1 – List of sources and mechanisms for common PCR inhibitors encountered 
in forensic DNA applications. 
 
Common strategies for inhibitor removal include performing a sample dilution or 
purification prior to amplification, using hot-start DNA polymerases that are less 
susceptible to inhibition, and/or adding extra DNA polymerase, bovine serum albumin 
(BSA), and/or magnesium to the PCR reaction (65, 69, 95). Although some of these 
removal techniques are effective, they may simultaneously decrease the amount of DNA 
Inhibitor Source(s) Mechanism(s) Reference 
Calcium Bone Inhibits DNA/Taq polymerase activity (65, 69, 95, 96) 
Collagen Tissues 
Inhibits DNA/Taq polymerase 
activity; binds with DNA 
template 
(65, 69, 95, 96) 
Detergents DNA extraction Denatures DNA polymerase (65, 69) 
EDTA DNA extraction Inhibits DNA polymerase activity (chelates Mg++ ions) (65) 
Hematin Blood Inhibits DNA polymerase activity (65, 69, 95, 96) 
Humic Acid Soil Binds with DNA template (65, 69, 95, 96) 
Melanin Hair and skin Binds with DNA template (65, 69, 95, 96) 
Nucleases Endogenous, environment Degrade template DNA (65, 69, 95, 96) 
Phenol DNA extraction Denatures DNA polymerase (65, 69) 





Degrade template DNA (65) 
Tannic Acid Leather, plants 
Inhibits DNA polymerase 
activity (chelates Mg++ ions), 
binds with DNA template 




recovered or amplified (65, 95). For example, sample dilution reduces both the inhibitors 
and template DNA, and NaOH or silica column purification often result in a loss of DNA 
(65, 69, 95). Furthermore, BSA addition is effective against some inhibitors, such as humic 
acid and melanin, but not for EDTA, NaCl, SDS, calcium, or collagen (65). Despite the 
potential loss of DNA with silica column purifications, other silica-based extraction 
methods, such as the use of silica-coated magnetic beads, efficiently remove inhibitors (65, 
69). Chaotropic salts, such as guanidinium thiocyanate, interfere with hydrogen bonds to 
increase the solubility of substances in an aqueous environment and are included in many 
commercial DNA extraction kits that use silica-based chemistries for DNA purification. 
They serve a dual purpose as they aid in both the denaturing of proteins and creating an 
environment for the silica substrate to selectively bind double-stranded DNA via an 
electrostatic and hydrophobic interaction (69, 100). 
Traditional Forensic DNA Workflow 
DNA Extraction 
Organic DNA extraction methods are traditional, yet still commonly used DNA 
extraction techniques, as they are efficient at extracting high molecular weight DNA in 
large amounts (101). However, they involve several harmful chemicals 
(phenol/chloroform), are labor intensive, and present more opportunities for contamination 
due to buffer preparation and the transfer of the solution to multiple tubes (64, 102, 103). 
As an alternative to ethanol precipitation following a phenol-chloroform separation, DNA 
can be collected and concentrated using a Microcon®-100 filter (MilliporeSigma, 
Burlington, MA), which can also collect lower molecular weight DNA that may not have 




Chelex®-100 is an ion-exchange extraction method that uses a chelating resin to 
bind divalent ions, which are typically cofactors for enzymes that degrade DNA (DNases) 
(105). While Chelex® is a simple method that reduces contamination opportunities, does 
not involve toxic reagents, and yields a large quantity of DNA, this process does not include 
any ‘clean-up’ step, and therefore any inhibitors other than the chelated ions are not 
removed from the solution. In addition, the chelating agents (resin) themselves cause PCR 
inhibition if they are not completely removed prior to amplification due to chelating the 
Mg++ ions required for Taq DNA polymerase (105). Chelex® has been reported as being 
efficient at extracting more DNA than organic methods in many cases (106) but may not 
perform as well compared to newer DNA extraction methods such as commercial silica-
based chemistries (33).  
Solid phase extraction methods using silica-based membranes in spin columns, or 
silica-coated magnetic beads, are based on the premise that DNA preferentially binds to 
the silica at a low pH and in the presence of chaotropic salts (9, 103, 107-110). While the 
DNA is strongly bound, proteins and other cell debris are washed away. Once in a high pH 
buffer and no chaotropic salts, the DNA no longer binds and is eluted (111). Many 
commercial kits such as the QIAamp® DNA Investigator Kit (QIAGEN, Hilden, 
Germany), PrepFiler® BTA Forensic DNA Extraction Kit (Thermo Fisher Scientific, 
Carlsbad, CA), E.Z.N.A.® Forensic Extraction Kit (Omega Bio-tek Inc., Norcross, GA), 
and the DNA IQ™ System (Promega Corporation, Madison, WI) have been produced 
specifically for the forensic market. Several studies have used commercial kits to extract 




body fluids and tissues (2, 3, 33, 105, 116, 118), with many reporting comparable or 
improved DNA recovery over the standard organic or Chelex methods (33, 100, 105, 112). 
DNA Quantification 
Quantitative real-time PCR, or qPCR, is the standard method used in forensics that 
allows for the determination of the concentration of DNA within a sample (119, 120). 
Several commercial qPCR kits have been designed specifically for the forensic community. 
These include Quantifiler® Trio (Thermo Fisher Scientific), Investigator® Quantiplex® Pro 
(QIAGEN), Investigator® Quantiplex® Pro RGQ (QIAGEN), PowerQuant® (Promega), 
and InnoQuant® kits (InnoGenomics) (Table 1.2). These kits determine several sample 
quality metrics, such as the amount of human autosomal and male DNA present in an 
extract, presence of inhibitors, and the degree of DNA degradation (118). The relative 
concentration of autosomal and male targets can also allow for the screening of 
female:male mixtures (118), which is especially helpful for sexual assault samples and the 
determination of the appropriate amplification strategy. For example, if there is a trace 
amount of male DNA in the presence of a high female DNA background, Y-STR typing 











TABLE 1.2 – Summary of commercial qPCR kits commonly used in forensics. 
Kit Name Manufacturer Overview of Targets 
Quantifiler 
Trio ThermoFisherScientific 
Short autosomal (80 bp), Long autosomal (214 




Short autosomal (91 bp), Long autosomal (353 
bp), Short male gonosomal (81 bp), IPC (434 
bp) 
Quantiplex 
Pro RGQ QIAGEN 
Short autosomal (91 bp), Long autosomal (353 
bp), Short male gonosomal (81 bp), Long 
male gonosomal (359 bp), IPC (434 bp) 
PowerQuant Promega 
Short autosomal (84 bp), Long autosomal (294 
bp), Short male gonosomal (81-136 bp), IPC 
(435 bp) 
InnoQuant InnoGenomics Short autosomal (80 bp), Long autosomal (207 bp), IPC (172 bp) 
*IPC = Internal Positive Control 
 
During forensic DNA workflows, the presence of inhibitors is most commonly 
predicted during DNA quantification (69). This is accomplished using PCR efficiency 
calculations and/or co-amplifying an internal positive control (IPC) (69). Although most 
DNA quantification and STR-typing chemistries have been optimized to be tolerant to a 
wide range of inhibition, some inhibitors may not have the same effect on the IPC target 
and downstream STR amplicons (69); for example, a sample might flag as inhibited during 
qPCR, but show no effects of inhibition during STR-typing, and vice versa. For low 
template samples that contain PCR inhibitors, the volume of DNA extract used for PCR 
amplification is generally much higher than for qPCR (15 µL vs 2 µL), and therefore, the 
effects of the inhibitors are compounded during PCR (120). In contrast, heavily inhibited 
samples that are flagged as such after qPCR are typically diluted prior to amplification, 





Quantifiler® Trio was the first commercially available qPCR kit designed to assess 
DNA degradation in a sample prior to genotyping (116). Two autosomal targets are 
included in the reaction: one short (80 bp) and the other long (214 bp) (118). Because 
longer DNA targets are more susceptible to degradation, the calculation of their relative 
amplification (short divided by long) gives a degradation index (DI) (116, 118).  Several 
studies have reported DI values as being generally indicative of the degree of DNA 
degradation (116, 118, 122, 123). The Quantifiler® Trio handbook reports that a sample is 
likely not degraded with a DI <1, slightly to moderately degraded with a DI of 1-10, and 
severely degraded with a DI >10 (124). However, Vernarecci further breaks this down into 
slightly different DI categories: 0-1.5 is non degraded, 1.5-4 is mildly degraded, 4-10 is 
degraded, and >10 is severely degraded (116). As with the detection of mixtures, knowing 
the level of DNA degradation prior to genotyping can also help analysts determine the most 
effective downstream PCR chemistry/workflow to use to generate the most probative 
information and save time and resources (116, 118). 
Investigator® Quantiplex® Pro RGQ is a DNA quantification kit that has been 
designed to pair with downstream genotyping kits, such as the Investigator® 24plex QS kit. 
It is a unique expansion of the Investigator® Quantiplex® Pro kit in that it includes a fifth 
target; an additional male target that can indicate the level of degradation of any male DNA 
in the reaction. This kit allows for the simultaneous detection of human autosomal and Y-
chromosomal degradation, the ability to monitor inhibition with its Internal Control (IC), 
and maintaining sensitivity, especially for male DNA in the presence of high amounts of 





STR Typing and Analysis 
The use of STRs for genotyping individuals is commonly known as genetic 
fingerprinting (54). STR markers are regions of DNA that are highly polymorphic and are 
abundant in the non-coding regions of the human genome (125). They consist of two to six 
basepair repeats, with four basepair (tetrameric) markers being most commonly used in 
forensic analyses due to their higher resistance to strand slippage of the polymerase (stutter) 
(5). Over the past 26 years, many commercial multiplex PCR kits have been designed to 
co-amplify 3-27 STR loci ranging from 60-500 bp (7, 126-129). With the expansion of the 
FBI CODIS core loci from 13 to 20 markers (plus amelogenin) in 2017, forensic companies 
had to design new STR kits to accommodate the additional core loci (Table 1.3) (130, 131). 
TABLE 1.3 – List of commercially available STR kits with the expanded CODIS core 
loci. 





10 mini-STRs, SE33, Y-INDEL 
and DYS391 
GlobalFiler IQC ThermoFisher Scientific 25 
10 mini-STRs, SE33, Y-
INDEL, DYS391, and Internal 
quality sensors (IQC system) 
VeriFiler Plus ThermoFisher Scientific 26 
11 mini-STRs, Y-INDEL, Penta 
D, Penta E, D6S1043, and 
Internal quality sensors (IQC 
system) 
Investigator 24plex 
QS/GO! QIAGEN 24 
SE33, DY391, and Internal 
quality sensors (QS markers) 
Investigator 26plex 
QS QIAGEN 26 
D6S1043, Penta D, Penta E, 
DY391, and Internal quality 
sensors (QS markers) 
PowerPlex Fusion Promega 24 Penta D, Penta E, DYS391 
PowerPlex Fusion 
6C Promega 27 
SE33, Penta D, Penta E, 






The GlobalFiler® PCR Amplification Kit (Thermo Fisher Scientific) is commonly 
used in forensic laboratories and is a 6-dye STR kit with 24 loci, of which 10 are mini-
STRs (<250 bps)  (131, 132). It is highly sensitive with a validated target DNA input of 
0.5-1 ng (depending on the cycle number used); however, several studies have reported full 
DNA profiles being produced from casework-type samples and diluted control DNA 
(pristine and spiked with inhibitors) with as little as 100 pg DNA (122, 131, 133). In 
addition, GlobalFiler® also includes several male targets (a Y-INDEL and DYS391) to 
monitor drop-out of the Amelogenin Y-allele (131, 132) due to mutations that result in a 
null allele.  
The Investigator® 24plex GO! and Investigator® 24plex QS (QIAGEN) kits are 
designed to STR-type reference (buccal swabs and FTA cards) and casework samples, 
respectively (130). In addition to the expanded CODIS core loci, Amelogenin, and two 
additional loci (SE33 and DY391), these STR kits also include two quality sensor markers 
that serve as an internal PCR control (130, 134, 135), similar to those included in many 
DNA quantification kits. Relative to the 74 bp QS1 (‘Q’) marker, the signal of the 435 bp 
QS2 (‘S’) marker tends to significantly decrease in height (or drop out) with PCR inhibition 
(130, 134, 135). However, in the presence of extreme inhibitor concentrations, both 
markers may completely fail to amplify. The observed difference in height or fluorescence 
(in relative fluorescent units; RFUs) of the QS markers can often assist in differentiating 
STR profiles that are of poor quality due to PCR inhibition, DNA degradation, failed 
amplification, or absence of DNA template (130, 134, 135) (Fig. 1.1). The information 
provided by the QS markers in the 24plex QS kit and the quality flags in the RGQ kit 




quality of the sample and resultant STR profile. Together, these data could ideally direct 
DNA analysts towards the most appropriate rework strategies as needed. Other commercial 
STR kits that integrate one or more quality control markers within the PCR multiplex 
include the Investigator® Argus X-12 QS, Investigator® Argus Y-12 QS, Investigator® 
ESSplex SE QS, and Investigator® 26plex QS kits from QIAGEN, and the GlobalFiler® 
IQC, VeriFiler® Plus, and NGM Detect® kits from Thermo Fisher Scientific. 
 
FIG. 1.1 - Examples of how QS markers behave with different DNA sample types. A) 
Confirmed successful PCR amplification. Small amplicon Quality Sensor peak (QS1) and 
large amplicon Quality Sensor peak (QS2) appear at similar heights. Sample allele peaks 
have balanced height across the profile. B) Confirmed successful PCR amplification but 
absence of DNA. QS1 and QS2 appear at similar heights. No sample allele peaks appear. 
C) Failed PCR amplification. Lack of QS1 and QS2. No sample allele peaks appear. D) 
Inhibited DNA. QS1 with normal peak height and QS2 with decreased peak height can be 
seen if inhibitors are affecting PCR. Sample allele peaks for the markers show decreasing 
height towards the larger markers. E) Degraded DNA. QS1 and QS2 appear at similar 
heights. Sample shows allele peaks for the STR loci with decreasing height towards the 





Due to the absence or extremely low amounts of amplifiable nuclear DNA in highly 
degraded skeletal remains (especially ancient remains), mitochondrial typing is commonly 
used as a last resort for HID when STR analysis fails (4, 7, 14, 19, 66). Most laboratories 
that sequence mtDNA focus on either hypervariable regions 1 and 2 (HVI/HVII) in the 
control region or on the coding region (25, 137). However, due to the maternal inheritance 
of mitochondrial DNA, the power of discrimination is much lower than STR typing (7, 19, 
66). It is therefore preferable to perform autosomal STR typing for HID purposes when 
possible. When LCN techniques were applied to the remains of missing military service 
members from WWI, WWII, and the Vietnam War, STR typing was able to provide gender 
determination, separate co-mingled remains, and resulted in the “first identification from 
the Vietnam War” using nuclear DNA (19).  
Although STR markers are commonly used in forensic analyses, the larger 
amplicon markers (>200 bp) are susceptible to allelic and/or locus drop-out in degraded 
samples (138). This results in incomplete profiles and therefore a lower power of 
discrimination. One of the most common alternate markers used are SNPs as they currently 
are used to supplement STR data (to aid with mixture interpretation, for example), with the 
potential of total replacement (23, 26, 139). While small amplicon sizes are attractive for 
degraded samples (24-26), it has been shown that approximately 50 SNP loci are needed 
to achieve the same discriminating power as 15 STR loci (23, 24, 140). However, small 
groups of linked SNPs within STR loci, called microhaplotype loci (microhaps), are a new 
and powerful type of forensic marker (139, 141). Microhaps are most relevant for lineage 
determination and mixture deconvolution (139). Another alternative method for typing 




polymorphisms (138, 142, 143). Similar to SNPs (140), these bi-allelic markers are widely 
found throughout the genome, have a low mutation rate, are able to be multi-plexed, can 
have a high power of discrimination for human identification, and have small amplicon 
lengths (<200 bp), which make them ideal for degraded samples (138, 142, 143).  
STR typing is most commonly performed with capillary electrophoresis-based 
methods (141, 144-146); however, massively parallel sequencing (MPS) is quickly 
becoming an attractive alternative. MPS technology allows for millions of DNA 
strands/fragments to be sequenced simultaneously (141, 144-146). Additionally, the use of 
barcodes allows multiple samples to be pooled together in a single run (146). Compared to 
Sanger sequencing, MPS increases sample throughput while decreasing the cost per sample 
(144). With traditional CE-STR kits, only a small number of loci (25-30) are able to be 
multiplexed, dye artifacts arise, and degraded samples may still result in no or partial 
profiles, even with mini-STR kits (144, 146). With MPS, alleles of similar/identical lengths 
can be distinguished based on the template or primer sequence without having to separate 
loci on different dye channels or moving primer locations (141). This allows multiplexed 
loci to have overlapping amplicon sizes, resulting in the smallest amplicon length possible, 
which is most beneficial for degraded samples (141, 144, 145). Also, the sequencing of 
STRs that contain SNPs increase the discriminatory power of that locus (141, 145). While 
PCR artifacts such as stutter and heterozygote imbalance are still present (141, 146), 
sequencing makes their identification simpler (145). For example, sequence variants can 
help distinguish stutter peaks from minor allele contributor peaks (144). While there are 
many advantages of MPS and the use of other genetic markers, these alternate methods 





Automation plays a key role in most forensic DNA laboratories due to the demand 
for a high throughput of samples. Some platforms such as the QIAgility (QIAGEN) are 
designed as a liquid handling instrument for setting up PCR reactions and CE plates. Other 
larger platforms such as the Hamilton Microlab® STARlet robot, the QIAsymphony® 
(QIAGEN), or TECAN systems (e.g. Fluent® or Freedom EVO®), can perform customized 
combinations of functions such as liquid handling, DNA extraction, and punching samples 
from FTA® cards, for a fully hands-free setup of databasing samples.  
There are several automated DNA/RNA extraction platforms available, including 
the EZ1 and EZ1 Advanced XL and QIAcube (both QIAGEN), Maxwell 16 (Promega), 
and the iPrep and AutoMate Express (Thermo Fisher Scientific) (103, 105, 110, 114, 147, 
148). These systems allow for multiple samples (up to 16) to be processed in under an hour. 
Many studies have shown that these platforms routinely generate high amounts of DNA 
from a wide range of forensically relevant samples for STR-typing (103, 105, 110, 114, 
147, 148). However, some studies have also reported substantial losses of DNA when 
extraction is performed on an automated platform (147). A study comparing the extraction 
of body fluids on the Biorobot EZ1 platform versus a manual organic method reported a 
30-40% decrease in DNA yield with automation, but this did not affect STR success or 
profile quality (147). In addition, some studies have also reported higher levels of DNA 
degradation and allelic drop-in in STR profiles of samples extracted using automated 
methods compared to other manual methods (103, 110, 114). Therefore, precious or LT-
DNA samples (such as bone), are traditionally not processed using automated processes 




automated DNA extractions using the QIAcube for their bone samples (110), most 
laboratories performing DNA extractions prefer to use manual methods such as a total 
demineralization followed by an organic or commercial kit DNA purification (10, 107, 
149, 150). Even though automated DNA extractions may not always yield higher amounts 
of DNA (105, 110, 147), automation may greatly reduce the processing time per sample, 
costs, variation, and the risk of contamination and human error (13, 103, 105, 110, 114, 
147, 148). 
DNA Extraction from Skeletal Samples 
For all forensic samples it is important that DNA extraction methods recover as 
much DNA as possible (14) while simultaneously eliminating unwanted contaminants and 
PCR inhibitors. This is especially true for methods extracting DNA from LT-DNA and 
degraded skeletal material (14). Early DNA extraction procedures were labor-intensive, 
time-consuming, costly and relatively inefficient (9, 109), but over the past two decades 
several DNA extraction methods have been developed as faster, simpler, and more 
effective kit-based technologies, which also have the potential for automation (11, 103, 
105, 108, 110, 114, 147, 151). However, despite some advancement in commercial DNA 
extraction kits, DNA purification is still relatively difficult and time consuming for bone 
and tooth samples. Many forensic laboratories that process bone samples tend to develop 
custom in-house protocols for bone preparation, digestion buffer constituents and 
incubation combinations, and DNA purification methods. However, regardless of the 
approach, all methods include general bone preparation, digestion/lysis/demineralization 
of the tissue, followed by purification, precipitation/elution, and concentration of DNA 




Sample Processing and DNA Purification 
Bone preparation consists of cleaning the external surface of the bone (via washing, 
UV radiation, and/or sanding), cutting the bone into smaller pieces (if necessary), and 
crushing the bone into powder with liquid nitrogen (9, 22, 64, 109, 152, 153). While finely-
ground bone powder often yields sufficient amounts of DNA (9, 10, 12, 44, 103, 107, 109, 
110, 113-115, 154-158), there is a risk of sample contamination and potential hazard to the 
processor from airborne powder (14, 64, 109, 158). Additionally, this process is more time 
consuming, requires specialized training (14), and equipment and supplies such as grinding 
vials, freezer mills, and liquid nitrogen. It must also be noted that powdering the bone tissue 
also destroys the bone sample. As a result, many studies have explored less-destructive 
sample preparation and DNA extraction methods from whole bone and teeth (22, 152, 156, 
158). This approach is most desirable in ancient DNA applications to preserve museum 
exhibits and ancestral remains (22, 152), but can also be applied to contemporary samples 
(156, 158).  
One study in 2004 by Rohland et al. demonstrated that digestion of ancient bone 
and teeth in a guanidinium thiocyanate (GuSCN) buffer for a week, followed by silica 
purification of the surrounding buffer solution, resulted in a 93% success rate for teeth and 
67% for bone with mitochondrial DNA typing (22). It was noted that there was no visible 
damage to the samples, only that they were cleaner than before (22). Due to the hazardous 
nature of GuSCN and the lack of amplifiable nuclear DNA in Rohland’s 2004 study, 
Bolnick et al. implemented a previously published complete demineralization protocol 
(109) with the exception of using whole bone versus powdered bone (152). The 




degradation and prevent decalcification to preserve the integrity of the 
archaeological/museum samples (152). While the teeth tested remained intact, the bone 
fragment that was tested partially disintegrated and smaller fragments completely dissolved 
(152). Although this may not be desired for historical or museum samples, the increased 
DNA yield provided through total demineralization may be considered essential when 
extracting DNA from challenging skeletal samples for human identification. 
Many forensic laboratories that perform DNA testing on human remains, such as 
the Armed Forces DNA Identification Laboratory (AFDIL) use a version of a complete 
demineralization digestion protocol (10, 12, 107, 155). Demineralization is the process of 
removing mineral ions, such as calcium in bone samples to allow cellular material 
containing DNA to be released (12). DNA is found in the osteocytes of bone, which are 
housed in a calcified bone matrix with approximately 20,000-26,000 osteocytes/mm3 (12, 
43, 159, 160). Approximately 70% of the mineral portion of bone is composed of 
hydroxyapatite (calcium carbonate, calcium phosphate, calcium citrate, etc.) (4, 10).  
While this arrangement protects the DNA from the environment, it also makes it 
difficult to access the DNA during the extraction process (12). Therefore, decalcification 
(demineralization) is needed to free the osteocytes by breaking down the matrix into 
calcium ions and other components (12). Demineralization extraction buffers generally 
contain high concentrations (0.5 M) of ethylene diamine tetra-acetic acid (EDTA) for this 
purpose, and to chelate the released calcium cations, which aids in the inactivation of 
DNAses (10). Although total demineralization releases more osteocytes, it also frees more 




and the ratio of bone tissue to buffer volume are thought to influence DNA extraction 
efficiency (10, 109, 114). 
Loreille et al. reported that when total demineralization was performed with 15 mL 
of 0.5M EDTA per gram of bone power,  a significantly higher DNA yield (228 times more 
DNA/g bone powder), and a lower amount of co-extracted PCR inhibitors was obtained 
when less bone powder was used (0.2 g vs 1-2 g of bone powder) (10). When AFDIL 
implemented their new DNA extraction protocol with a reduced amount of powdered bone 
(0.2 g compared to 2.5 g), an increase in the number of submissions to identify skeletal 
remains’ fragments was observed (17). With this decrease in the minimum amount of bone 
powder required, DPAA scientists were able to process previously “untestable” materials 
(17).  
In early 2019, Edson reported a comprehensive evaluation of human remains’ 
testing performed at AFDIL from 1990 to mid-2018 and suggested that sampling strategies 
should take into consideration a greater applicability and more testing platforms, such as 
next-generation sequencing (NGS) or massively parallel sequencing (MPS), mitochondrial 
sequencing, and STR platforms (17). During that evaluation study, four main extraction 
methods were used by AFDIL for fully skeletonized remains with post-mortem intervals 
(PMIs) of 40-100 years: 1) an incomplete demineralization followed by an organic 
purification; 2) a complete demineralization followed by an organic purification; 3) a 
complete demineralization followed by an inorganic purification (QIAquick PCR 
purification kit); and 4) a protocol designed specifically for NGS testing (17). Additionally, 
the success of each of these methods was compared across five different DNA typing 




sequencing); 2) modified Y-Filer STR typing; 3) MiniFiler STR typing; 4) PowerPlex 
Fusion STR typing; and 5) NGS (17). 
The overall findings of the study revealed that rather than focusing on which 
skeletal elements yield the highest DNA amounts and genotyping success, choosing the 
most effective combination of extraction and DNA typing methods was the most important 
factor to consider (17), which has also been generally suggested before (114). For example, 
while the complete demineralization and inorganic purification method generated the best 
results for all STR platforms, the complete demineralization with an organic purification 
produced better results when mitochondrial sequencing was performed, regardless of the 
skeletal element tested (17). Additionally, when evaluating different sample insults, it was 
shown that both of the complete demineralization protocols resulted in the most complete 
STR profiles from chemically contaminated remains such as those recovered from the USS 
Oklahoma (oil soaked remains) (17). 
In 1986, Weiner and Price first described the presence of crystal aggregates of bone 
matrix (161). These fused crystals were shown to be resistant to oxidizing agents, such as 
sodium hypochlorite (NaOCl) (153, 161). A later study revealed that the DNA fragments 
contained within isolated crystal aggregates were well preserved and less degraded than 
DNA extracted from whole bone powder (153). It was therefore suggested that total 
demineralization may allow for the enhanced release of crystal aggregates that contain 
large fragments of DNA (10). By using less bone powder, the buffer to sample ratio is 
much higher, allowing for more efficient demineralization and chelation of calcium ions, 
and therefore, the extraction of more DNA from the crystals and less inhibitors (10, 109). 




STR success from skeletal samples compared to using an extraction buffer with a much 
lower concentration of EDTA (9, 70, 109, 110, 114, 155). While these methods are able to 
extract high quantities of DNA, they are time-consuming (24 to 120 hours) and require a 
significant amount of sample handling (9, 10, 64, 107, 155). 
In 2010, a new bone digestion kit, TBone EX kit (DNA Chip Research Inc., Tokyo, 
Japan), was developed that releases DNA from whole bone chips to eliminate the need to 
powder the bone tissue (156). Digestion of a whole bone fragment followed by a silica-
based purification yielded approximately three times more DNA than those samples 
demineralized and purified using an organic method (156). With the non-powdering 
protocol, three out of four femur fragments resulted in full profiles with a traditional STR 
kit, and the fourth provided a full profile when a mini-STR kit was used (156). In addition, 
the bone chips were not totally consumed during the first round of extractions with the 
TBone kit, and therefore provided an opportunity to perform further extractions from the 
same chip rather than consuming additional bone samples (156). 
A complete demineralization digestion step can be coupled with any DNA 
purification method. Several studies have shown that silica-based extraction from degraded 
bone samples reduced the amount of inhibition in the extract and increased the DNA yield 
and number of full profiles compared to a standard phenol/chloroform method (11, 157, 
162).  Both silica-based spin columns and magnetic bead filtration extraction methods also 





Statement of the Problem 
Since the attacks on the World Trade Center in 2001, the forensic DNA community 
has focused on improving different methods for the identification of challenging forensic 
samples and skeletal samples in particular. In general, the entire process of DNA profiling 
from skeletal samples is time consuming and requires some specialized equipment and 
training, and therefore some innovative solutions to make these processes faster and easier 
could benefit forensic laboratories.  
Additionally, manufacturers can only access limited types of samples when 
performing developmental validations of their products, and most forensic laboratories do 
not have the time or resources to stress-test new products. As a result, published works 
from independent researchers with access to unique and challenging sample types, and the 
ability to explore the wider application and performance of commercial products, are relied 
upon as unbiased data to support the adoption of new methodologies within the 
medicolegal community. 
This research focused on providing alternative solutions to problems commonly 
encountered throughout forensic DNA workflows by evaluating and optimizing protocols 
for sample processing, DNA extraction, and STR typing for the identification of human 
skeletal remains and other challenging biological samples. The overall work was 
performed in four parts. Phase 1 investigated the efficiency of an alternate bone processing 
and DNA extraction method (TBone Ex kit) for a variety of bone samples. The TBone Ex 
buffer eliminates the entire bone powdering process, and also allows for a second round of 
extractions from the same bone sample. In phase 2, a whole-bone digestion method using 




chip size and number and digestion time. Phase 3 examined the effect of increasing the 
number of PCR cycles in a commercial STR kit when using two different extraction 
methods to purify DNA from environmentally challenged bone and tooth samples. Finally, 
Phase 4 explored the application of Quality Sensor (QS) markers in determining the most 
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Bones are often recovered in forensic investigations, including missing persons and 
mass disasters. While traditional DNA extraction methods rely on grinding bone into 
powder prior to DNA purification, the TBone Ex buffer (DNA Chip Research Inc.) digests 
bone chips without powdering. In this study, six bones were extracted using the TBone Ex 
kit in conjunction with the PrepFiler BTA™ DNA extraction kit (Thermo Fisher 
Scientific) both manually and via an automated platform. Comparable amounts of DNA 
were recovered from a 50 mg bone chip using the TBone Ex kit and 50 mg of powdered 
bone with the PrepFiler BTA™ kit. However, automated DNA purification decreased 
DNA yield (p < 0.05). Nevertheless, short tandem repeat (STR) success was comparable 
across all methods tested. This study demonstrates that digestion of whole bone fragments 
is an efficient alternative to powdering bones for DNA extraction without compromising 
downstream STR profile quality. 
 





Evaluation of a Powder-free DNA Extraction Method for Skeletal Remains 
Introduction 
In order to generate a high-quality short tandem repeat (STR) profile, it is optimal 
to extract a sufficient quantity of high quality DNA (>100 pg without low-template 
techniques (1-3)) while simultaneously eliminating unwanted contaminants and PCR 
inhibitors. DNA extraction procedures can be labor-intensive, time-consuming, include 
toxic chemicals, and be relatively inefficient (4, 5). Over the past two decades, several 
DNA purification methods have developed as faster, simpler, and more effective kit-based 
technologies with the potential for automation (6-13). However, despite some advancement 
in commercial DNA extraction kits, DNA extraction is still relatively time consuming for 
skeletal remains due to lengthy sample preparation including cleaning, processing, and the 
requirement for crushing bone into a fine powder prior to digestion (4, 5).  
Bone preparation consists of cleaning the external surface of the bone (via washing, 
UV radiation, and/or sanding), cutting the bone into smaller pieces (if necessary), and 
crushing the bone into a powder with liquid nitrogen in a blender cup or a freezer mill (4, 
5, 14-18). While finely-ground bone powder generally yields type-able amounts of DNA 
(4, 5, 7, 12, 13, 18-28), it destroys the sample, increases the risk of contamination, and 
creates a potential hazard to the processor from airborne powder (4, 17, 27). Therefore, 
several studies have explored non-destructive extraction methods from whole bone and 
teeth (14, 16, 23, 27). This approach is most desirable in ancient DNA applications to 
preserve museum exhibits and ancestral remains (14, 16), but could also be applied to 




Many forensic laboratories that perform DNA testing on skeletal remains use a 
version of a complete demineralization digestion protocol (18, 20-22). Demineralization is 
the process of removing mineral ions, such as calcium in bones, to allow the release of 
DNA from cellular material (22). Demineralization extraction buffers generally contain 
high concentrations of ethylene diamine tetra-acetic disodium salt (EDTA) to chelate the 
free Ca++ and Mg++ cations, which aids in the inactivation of DNases (18). Weiner and 
Price (29) first described the presence of crystal aggregates in bone matrix, which were 
later thought to house and protect sources of DNA (in osteocytes) from environmental 
degradation (18). These aggregates could therefore be a valuable source of DNA that could 
be released (15, 18) during a complete demineralization step. Several studies have reported 
that complete decalcification increases DNA yield and STR profile quality (number of 
reported alleles, peak heights, peak height ratios, etc.) from skeletal remains compared to 
using an extraction buffer with a much lower concentration of EDTA (4, 5, 12, 13, 20, 30). 
A complete demineralization digestion step can be coupled with any DNA purification 
method such as organic or silica-based methods.  
The TBone Ex kit (DNA Chip Research Inc.) is a bone digestion buffer system that 
was developed to release DNA from whole bone chips rather than finely powdered bone 
tissue (23). The bone chips may not be totally consumed during the first round of 
extractions with the TBone Ex kit and therefore could provide an opportunity to perform 
further extractions from the same chip rather than consuming additional bone (23). 
Although the TBone Ex kit can be coupled with many commercial DNA extraction kits, 




(PrepFiler® BTA™ Forensic DNA Extraction Kit automated on the Automate Express™ 
platform (Thermo Fisher Scientific).  
Automation plays a key role in most forensic DNA laboratories. There are several 
automated DNA extraction platforms available that allow for multiple samples to be 
processed in under an hour (6, 7, 11-13, 31). Although automated DNA extractions may 
not always yield higher amounts of DNA (6, 11, 13), automation can greatly reduce the 
processing time per sample, decrease run-to-run variation, and minimize the risk of 
contamination and human error (6, 7, 11-13, 31). Traditionally however, precious bones 
are not subjected to automated processes due to reduced control and concern for DNA loss.  
This project investigated the efficiency of extracting DNA from whole bone chips 
using a powder-free digestion method (TBone Ex kit). We compared DNA yield and STR 
profile quality when bone chips were processed using the TBone Ex Kit and when bone 
powder was extracted using a total demineralization protocol (18) or a commercial DNA 
extraction kit commonly used in forensic laboratories (PrepFiler® BTA™ Forensic DNA 
Extraction Kit, with and without automation). 
Materials and Methods 
Sample Preparation  
Bone samples (n=6) were collected from human cadavers exposed to various 
environmental insults at the Applied Anatomical Research Center (AARC) [previously 
named Southeast Texas Applied Forensic Science (STAFS) Facility] at Sam Houston State 
University (Table 1). For bones that were sampled prior to complete skeletonization, 
desiccated connective tissue was removed directly with a scalpel or via maceration. The 




shavings (~50 mg each) from the same region using a Dremel® tool (Dremel, Racine, WI, 
USA) before being washed with a series of 5 min washes of the following: 1% NaOCl three 
times, autoclaved distilled water three times, and a final 100% ethanol wash. The bone 
chips were dried in an oven overnight at 30°C. The bone chips were crushed in a SPEX 
6750 Freezer/Mill® (SPEXSamplePrep, Metuchen, NJ, USA) using the following 
conditions: 10 min cooling period followed by two cycles of one min crushing with a two 
min break between the crushing cycles. The bone shavings (50 mg) proceeded directly to 
extraction using the TBone Ex kit (DNA Chip Research Inc., Tokyo, Japan). An extraction 
blank was performed by wetting a cotton swab with sterile water and swabbing the inside 
of the freezer-mill tubes. 
DNA Extraction 
All bones (n=6) were extracted in triplicate, yielding a total of 18 extracts for each 
of the five methods. The swab extraction blank and a reagent blank were both processed in 
parallel with each extraction procedure to monitor contamination.  
One set of bone powders was extracted manually according to the PrepFiler® BTA™ 
Forensic DNA Extraction Kit (Thermo Fisher Scientific, Waltham, MA) following the 
Bone and Tooth protocol with 50 mg bone powder (32). Another 50 mg of the same bone 
powder was extracted using the PrepFiler® Express™ BTA™ Forensic DNA Extraction Kit 
on the Automate Express™ platform (Thermo Fisher Scientific) (33).  
All 50 mg bone shavings were demineralized and digested according to the TBone 
Ex Bone Decalcification Kit protocol as previously described (23) followed by DNA 
purification using the PrepFiler® BTA™ Forensic DNA Extraction Kit manually or 




TABLE 2.1 - Source information and DNA quantity for the six bone samples used in this study. Data shows the average DNA 
concentration (ng DNA/mg bone) and the coefficient of variance (CV) for each bone sample. Each sample was extracted in triplicate. 
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1 Femur Advanced Decomposition 0.018 3.46 0.013 14.11 0.009 24.76 0.010 17.96 0.004 22.49 
2 Tibia Skeletonized 0.035 9.79 0.025 10.10 0.014 6.22 0.036 85.54 0.007 17.79 
3 Femur Skeletonized 0.054 24.82 0.033 13.92 0.022 13.11 0.039 7.96 0.018 58.95 
4 Tibia Advanced Decomposition 0.361 14.37 0.298 15.88 0.227 2.60 0.182 13.28 0.034 48.76 
5 Femur Severely Burned 0.544 9.31 0.373 22.14 0.270 5.83 0.543 27.17 0.132 64.02 
6 Humerus Embalmed 3.224 15.98 0.756 24.93 0.166 20.59 0.500 95.98 0.010 62.39 




For comparison purposes, a final set of powdered bone (50 mg) was extracted 
according to a previously published purification protocol using complete demineralization 
and MinElute® PCR Purification columns (QIAGEN, Hilden, Germany) (34) with an 
incubation time of 20 hours and centrifugation at 2500 x g for 23 mins during the initial 
concentration step. All extracts were eluted in 50 µL.  
DNA Quantification and STR Analysis 
The amount of DNA in each extract was determined via quantitative real-time PCR 
(qPCR) using the Quantifiler® Trio DNA Quantification kit (Thermo Fisher Scientific) as 
per manufacturer’s instructions (35) on a 7500 Real-Time PCR System (Thermo Fisher 
Scientific). Data were accepted with an R2 value of 0.99 or above.  
All extracts were amplified using the GlobalFiler® PCR Amplification Kit (Thermo 
Fisher Scientific) with a target of 0.8 ng (when available) as per manufacturers’ protocol 
on a GeneAmp® PCR System 9700 (Thermo Fisher Scientific) (36). Detection of amplified 
products was performed using the 3500 Genetic Analyzer (Thermo Fisher Scientific) with 
a 36-cm capillary and POP-4 polymer (Thermo Fisher Scientific). DNA profiles were 
generated using GeneMapper ID-X v4.1 software (Thermo Fisher Scientific) with an 
analytical threshold of 150 relative fluorescent units (RFUs) and stochastic threshold of 
600 RFUs.  
Statistical Analysis 
Parametric assumptions were tested for using a Shapiro-Wilk’s W test. Data were 
tested for statistical significance by ANOVA single factor, followed by Tukey HSD post 
hoc comparisons when appropriate. p < 0.05 was accepted as the level of significance. 
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Results and Discussion 
DNA Yield  
Overall, the manual total demineralization method yielded the highest amount of 
DNA per mg of bone with an average of 0.71 ± 0.28 ng DNA/mg of bone (Fig. 2.1). This 
result supports previous studies (5, 12-14, 18, 20) that also report that the total 
demineralization protocol by Lorielle et al. consistently yields greater amounts of DNA 
from bone than other methods. The lowest DNA yield was obtained when the TBone buffer 
was used in combination with the PrepFiler® BTA™ extraction automated on the robotic 
platform (0.03 ng ± 0.01 DNA/mg of bone) (Fig. 2.1). In general, the DNA yields in this 
study are comparable or higher than reported for similar skeletal remains in previous 
studies (7, 12, 19, 23-25, 28, 34). Variation in DNA quantity between the technical 
replicates was observed (Table 2.1). As may be expected, more variation was seen when 
DNA extraction was performed from bone chips versus bone powder (average of 2.4 to 3.7 
times greater) (Table 2.1). Parametric assumptions were not met in some cases where it 
was deemed reasonable to continue with ANOVA statistics. There was a statistically 
significant difference between the various extraction methods as determined by one-way 
ANOVA (F4,85 = 3.839, p = 0.006), and therefore, a post hoc analysis was performed.  
Post hoc comparisons using the Tukey HSD test indicated that the mean score for 
total demineralization (M = 0.71, SD = 1.41) was significantly different than the automated 
PrepFiler® BTA™ extraction (M = 0.12, SD = 0.01) and TBone buffer paired with the 
automated PrepFiler® BTA™ extraction (M =0.034, SD = 0.003). However, no statistical 
difference was observed in the average DNA yields when PrepFiler® BTA™ was performed 
manually with or without the TBone Ex digestion steps (Fig. 2.1). These data may suggest 
66 
 
that the PrepFiler® BTA™ lysis buffer may be equally aggressive in digesting powered 
bone tissue as the TBone Ex buffer digests whole bone chips.   
FIG. 2.1 - Comparison of DNA yield per mg of bone (chip or powder) based on the 
extraction method used. n=18. *p < 0.05, **p < 0.01. Data are presented as mean + 
SEM. 
 
The decrease in DNA yield we observed when DNA extraction was automated is 
consistent with previous studies (11-13). Automation may also pose other risks such as the 
inability to control the pipetting, which led to two extracts in this study having a reduced 
elution volume (20 μL vs 50 μL) due to bubbles accumulating in the pipette tips. One of 
the samples was re-extracted, but the other was not due to limited sample. The reported 
data for this sample reflects the lower elution volume. While an infrequent occurrence, this 
could be detrimental in cases that have a very small amount of bone available for testing 
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Previous studies have reported high DNA yields when the TBone Ex kit was used 
to digest bone fragments prior to DNA purification (23, 24) and that multiple rounds of 
digestion may be performed on a single fragment (23). In that study, digestion of a whole 
bone fragment followed by silica purification yielded approximately three times more 
DNA than those demineralized and purified with an organic method using 560 mg bone 
chips (23). However, in our study, when much smaller fragments (50 mg) were digested 
with the TBone Ex buffer and PrepFiler® BTA™ extraction, DNA yields were comparable 
to the powdering methods (Fig. 2.1). This difference may be due to the smaller bone 
fragments and/or the difference in DNA purification kits used in the two studies. 
Nevertheless, the TBone Ex buffer provides a simple and efficient alternative to powdering 
bone tissue, which can reduce the risk of contamination and processing time.  
All the bone powder was dissolved using the total demineralization protocol while 
a slurry of bone powder remained after the initial PrepFiler® BTA™ digestion and lysis 
step. Although the 50 mg bone shavings incubated in the TBone buffer remained 
apparently intact, they were smaller in size, showing evident signs of dissolution. A 
previous study with the TBone buffer (23) has shown that DNA yields from three 
subsequent extractions were each higher than the first one. However, the previous study 
used bone chips that were ten-times larger than the 50 mg shavings used in this study. 
Although a second round of extraction could theoretically be performed using the TBone 
Ex buffer, the 50 mg chips were too small and were mostly digested in the first round.  
According to Loreille at al. (18), more calcium products are released during total 
demineralization, which may cause some PCR inhibition. However, no PCR inhibition was 
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detected with any DNA extracts during the qPCR assay. Additionally, all negative 
controls/reagent blanks showed no signs of contamination. 
STR Profile Quality 
Although parametric assumptions were not met in some cases, it was deemed 
reasonable to continue with ANOVA statistics.While there were differences in DNA yield 
between the various extraction methods, the average number of reportable alleles was 
comparable as determined by one-way ANOVA (F4,85 = 2.092, p = 0.089). All methods 
produced STR profiles with >75% average alleles reported (Fig. 2.2A). Although no 
statistical significance was found, our data support other studies that report a higher 
percentage of reported alleles when a complete demineralization digestion was performed 
compared to other DNA extraction methods (12-14, 18, 20). The average percent of alleles 
reported for the total demineralization method was 96.48 ± 1.72% while the other methods 
ranged from 75.58 ± 7.75% to 87.70 ± 4.77% (Fig. 2.2A).  
No statistically significant difference in average peak height ratio (PHR) was 
observed in the STR profiles generated from DNA extracted using the various extraction 
methods tested in this study as determined by a one-way ANOVA (F4,85 = 2.425, p = 0.054) 
(Fig. 2.2B). However, the extraction method was found to affect the average peak heights 
(in RFUs) of the STR profiles (F4,85 = 2.774, p = 0.032) (Fig. 2.2C). Post hoc comparisons 
indicate that the average peak heights of the total demineralization (M = 2662, SD = 1605) 
and automated PrepFiler® BTA™ (M = 2666, SD = 2159) profiles were significantly higher 
(p < 0.05) than those from the TBone Ex buffer paired with the automated PrepFiler® 






FIG. 2.2 - Comparison of STR profile quality between the different DNA extraction methods based on (A) percentage of alleles reported; 
(B) average peak height ratio; (C) average peak height (ANOVA (F4,85 = 2.774, p = 0.032)). n=18. *p < 0.05. Data are presented as 








The results of this study show that powdering of bone tissue may be avoided 
without significantly reducing DNA yield and STR profile quality. Although the complete 
demineralization method seemed to extract the most DNA per mg of bone and generate the 
most complete STR profiles, no statistical difference was observed when compared to the 
other two manual methods tested in this study (PrepFiler® BTA™, and TBone Ex kit 
coupled with the PrepFiler® BTA™ kit).  
While automation reduces processing time and the potential for human error, some 
technical issues may still occur with robotic platforms. Overall, a decrease in DNA 
concentration and STR profile quality was observed in cases when bones were extracted 
using an automated platform. Sample loss, such as a decreased elution volume, can be 
detrimental to the success of downstream genotyping, especially in cases when minimal 
bone tissue is available for analysis. Therefore, manual methods may be preferred.  
Our data indicate that manual DNA extraction from whole bone chips (using the 
TBone Ex kit) is comparable to traditional complete demineralization and the PrepFiler® 
BTA™ methods that require powdering of the bone tissue prior to extraction. However, 
results also suggest that the PrepFiler® BTA™ lysis buffer may be equally effective in 
digesting powered bone tissue as the TBone Ex buffer digests whole bone chips.  
Nevertheless, avoiding the powdering steps during bone preparation can reduce the 
risk of contamination, the initial processing time by approximately 15 minutes per bone 
(depending on the powdering method used), and the potential for bone powder loss during 
grinding. In addition, if a sufficient amount of bone chip remains, another round of 
extraction may be possible from the same bone fragment. This option is not possible when 
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bones are powdered and consumed during digestion. It should also be noted that the bones 
used in this study were contemporary (< 6 years). Further work would need to be performed 
on older bones to determine the efficiency of the TBone Ex buffer with more highly 
degraded and ancient specimens. 
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The processing of skeletal material poses several challenges for forensic 
laboratories. Current methods can be laborious, time-consuming, require dedicated 
equipment, and are vulnerable to contamination. In this study, various sample mass 
(1x50mg, 3x50mg, and 1x150mg chip(s)) and incubation times (2, 4, and 16hrs) were 
tested using the PrepFiler® BTA™ Forensic DNA Extraction Kit to digest whole bone chips 
in lieu of powdering. The most effective method was then applied to bones and tooth 
fragments collected from contemporary human cadavers exposed to various environmental 
conditions using an automated platform. Over a third of the samples tested generated full 
DNA profiles without having to powder the bone/tooth fragment, or further alter the 
manufacturer’s protocol. However, for most samples resulting in incomplete STR profiles 
due to low amounts of DNA, slightly better results were achieved with powdered tissue. 
Overall, this work demonstrates the potential use of a faster, non-powdering DNA 
extraction method for processing skeletal samples as an effective first-pass screening tool. 
 
Keywords: forensic science; forensic biology; DNA; bone; short tandem repeats; 
skeletonized human remains; PrepFiler® BTA™ forensic DNA extraction kit
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A Powder-free DNA Extraction Workflow for Skeletal Samples 
Introduction 
While the testing of blood, epithelial cells via buccal swabs, or other soft tissues 
are typically the preferred samples for identifying deceased individuals via DNA typing, 
these samples may be unavailable or highly decomposed in forensic cases, or in situations 
such as missing persons and mass disasters (1-3). Hard tissues, such as bones and teeth, are 
often the only remains available for analysis, which can provide a challenge for the human 
identification process (2-13). Such considerations include degraded and/or low amounts of 
DNA, small amounts of bone available for analysis, lengthy and specialized sample 
preparation, and exogenous DNA contamination from either co-mingled remains or 
handling during the collection and processing steps (2-9, 14-17).  
Many agencies and laboratories traditionally collect or are provided with whole 
teeth or samples from the cortical portions of weight-bearing long bones (femur, tibia, and 
humerus) for DNA analysis. This preference and generalized recommendation has been 
drawn from several studies that have shown these elements to have the highest success 
rates for achieving the most complete DNA profiles (2, 6, 11, 17-23). However, due to the 
requirement of large amounts of starting material (0.5–5+ g) for some DNA extraction 
methods (4, 7, 12-14, 19, 23-26), many of these studies did not include partial tooth 
fragments or various smaller bony elements such as those from the hands, feet, and skull 
that do not meet the mass requirement, but may be more commonly recovered from human 
remains (6). A growing number of more recent studies have provided evidence that higher 
DNA and allele recovery may be obtained from some smaller and less frequently sampled 
bony elements such as phalanges of the hands and feet, as well as petrous bones in the skull 
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(2, 6, 22, 27-31). The increasing efficiency of DNA extraction methods for skeletal remains 
(with as little as 50 mg starting material required (8, 32-34)) and sensitivity of STR kits 
have made it possible for a wider variety of sampling options that include these alternate 
skeletal elements.  
Traditional bone processing includes decontamination using various combinations 
of UV radiation, bleach and ethanol washing steps, and surface removal via sanding prior 
to grinding into a fine powder (4, 5, 8, 14-16, 24-26, 35). However, powdering bone 
destroys the sample and requires specialized equipment and laboratory conditions. This 
additional step in sample handling is commonly performed in a blender cup or a freezer 
mill with liquid nitrogen (4, 7, 12, 14, 24-26) with a fine, airborne powder posing a possible 
biological hazard for the processor and increasing the risk of sample contamination (5, 14, 
15, 36). Despite these concerns, using powdered bone for DNA extraction has remained 
the sample processing method of choice due to its reported success in literature and 
casework, and with very few studies investigating alternate approaches.  
Most laboratories that process skeletal samples crush bone into a fine powder and 
use aggressive digestion buffers with high concentrations of EDTA to demineralize the 
bone powder through the chelation of mineral ions, such as Ca++ (4, 7, 8, 12-14, 25, 35, 37, 
38). The complete demineralization of bone powder releases high amounts of DNA into 
solution, likely from crystal aggregates that may provide protection against environmental 
degradation (7, 35, 39) and therefore are valuable sources of DNA for human identification.  
Although powdering bone is the most common method for forensic laboratories, 
some studies have demonstrated the use of less destructive methods to leach DNA from 
bone and teeth into solution and obtain successful DNA profiles (5, 10, 34, 36, 38, 40, 41). 
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While this approach has been primarily used for ancient remains and other museum 
samples (38, 40, 41), its application may also extend to contemporary skeletal remains for 
forensic applications. In a previous study, it has been shown that comparable DNA yields 
and STR profile quality can be achieved via the digestion and extraction of whole bone 
chips (50 mg) compared to other traditional methods that use powdered bone (34). 
However, the digestion of bone chips was performed with a different suite of buffers; the 
TBone Ex kit (DNA Chip Research Inc., Tokyo, Japan). While these buffers eliminated 
bone powdering steps, were convenient, and coupled as a pre-treatment for a commercial 
DNA extraction kit, the lengthy overnight incubation and additional sample handling and 
reagent costs could not be avoided. Therefore, investigating the effectiveness of a single 
commercial DNA extraction kit to rapidly process whole bone chips is of value.  
Additional strategies for increasing sample through-put for skeletal remains include 
the use of automation during the DNA extraction steps. Although automation has been 
shown in several studies to decrease DNA yield from challenging samples (and in some 
instances also allele recovery downstream), the amount of DNA recovered can still be 
sufficient to yield full STR profiles (8, 25, 34, 42-45). Despite these concerns, automation 
can mitigate many human errors, sample contamination, and inter-run variation (8, 25, 42-
45).   
This project involved two parts: In Phase 1, two variables (the size and number of 
bone chips and incubation time in the lysis buffer) were evaluated to determine the most 
effective protocol for extracting DNA from whole bone chips using a commercial DNA 
extraction kit. In Phase 2, the best combination of experimental conditions from Phase 1 
were then applied to twenty bones and five partial tooth fragments collected from nine sets 
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of contemporary skeletal remains that were environmentally challenged (fire exposure, 
embalming, burial, and advanced decomposition). These results were compared to 
traditional sample processing (powdering) and a traditional DNA extraction method 
(complete demineralization protocol). The efficiency of using an automated platform as a 
potential screening and/or first-pass processing tool for bone samples within crime labs 
was also investigated.  
Materials and Methods 
Sample Preparation  
Bone (n=21) and tooth (n=5) samples were collected from nine human cadavers 
exposed to various environmental insults at the Applied Anatomical Research Center 
(AARC) at Sam Houston State University (Table 3.1). For bones that were sampled prior 
to complete skeletonization, desiccated connective tissue was removed directly with a 
scalpel or via maceration. Broken tooth fragments were gently cleared of any soft tissue by 
hand and the surface (1 mm) of each bone was sanded and then cut into ~600 mg of 
moderate-sized pieces (5-8 mm2) or thin bone chips (~50-150 mg each) (Fig. 3.1) from the 
same region of compact bone using a Dremel® tool (Dremel, Racine, WI, USA). To achieve 
the appropriate weight of bone chips (± 0.5 mg of target weight), a small piece of bone was 
cut from the bone source, weighed, and if needed, further shaved down with the Dremel® 
until the desired weight was reached. Bone cuttings and tooth fragments were washed with 
a series of 5 min washes of the following: 10% bleach, autoclaved distilled water twice, 
and a final 100% ethanol wash. All bone cuttings and tooth fragments were allowed to dry 
in a fume hood overnight at room temperature; however, they were dry in under 3 hours 
and could therefore be processed the same day if desired. The bone cuttings were then 
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crushed in a SPEX 6750 Freezer/Mill® (SPEXSamplePrep, Metuchen, NJ, USA) the next 
day using the following conditions: 10 min cooling period followed by one cycle of 5 min 
crushing at 15 impacts per second. An extraction blank was performed by wetting a cotton 
swab with sterile water and swabbing the inside of the freezer mill tubes. The bone chips 
(50-150 mg) and tooth fragments were not powdered but proceeded directly to extraction 
using the PrepFiler® BTA™ Forensic DNA Extraction Kit (Thermo Fisher Scientific, 
Waltham, MA) (32).  
 





TABLE 3.1 - Information for samples used in Phase 1 and 2. LQ = Low DNA 





# Bone/Tooth Insult 
Phase 1 
A LQ humerus & tibia buried (2 years) 
B HQ femur burned* 
Phase 2 
C 1 femur embalmed using a formalin-based fixative solution 2 humerus 
A 
3 rib end 
buried (2 years) 4 humerus 5 femur 
6 tibia 
D 
7 hand phalanx 
decomposed remains 




11 foot phalanx 
E 
12 femur burned*, then further cremated in an 
outdoor fire pit 13 vertebral transverse process 
F 
14 hand phalanx 
burned* 






G T1 root (unknown tooth) decomposed remains (3 months on surface) T2 premolar fragment 
H T3 incisor fragment burned* 
B T4 premolar fragment burned* 
I T5 canine fragment burned* 
* Burnt bodies were doused with accelerant, set alight, and allowed to burn until the fire 







For Phase 1, three variations of each variable (bone chip mass: 1x50 mg chip, 3x50 
mg chips, and 1x150 mg chip; and incubation time: 2, 4, and 16 hrs) were tested in tandem 
for a total of nine combinations with five replicates each (n=45). As a set of controls, 50 
mg and 150 mg aliquots of powdered bone from each sample were also tested in the same 
manner (n=30). All samples were extracted manually according to the PrepFiler® BTA™ 
Forensic DNA Extraction Kit (Thermo Fisher Scientific) following the Bone and Tooth 
protocol (32) with the exception of the test variables. 
For Phase 2, all bone chips were demineralized and digested using the PrepFiler® 
BTA™ Forensic DNA Extraction Kit automated on the Automate Express™ platform 
(Thermo Fisher Scientific) (32, 46) with the optimal conditions identified in Phase 1 (50 
mg bone chip with 2 hr incubation) (Appendix Fig. B1). For comparison purposes, two sets 
of powdered bone were extracted manually with either the PrepFiler® BTA™ Forensic 
DNA Extraction Kit (Thermo Fisher Scientific) or according to a previously published 
purification protocol using complete demineralization and MinElute® PCR Purification 
columns (QIAGEN) (47) (Appendix Fig. B1). The total demineralization protocol was 
performed with an incubation time of 20 hrs and centrifugation at 2500 x g for 23 mins 
during the initial concentration step. All DNA extracts were eluted in 50 μL. Swab 
extraction and reagent blanks were both processed in parallel with each extraction 
procedure to monitor contamination. 
DNA Quantification and STR Analysis 
The amount of DNA in each extract was determined via quantitative real-time PCR 
(qPCR) using the Quantifiler® Trio DNA Quantification kit (Thermo Fisher Scientific) as 
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per manufacturer’s instructions (48) on a 7500 Real-Time PCR System (Thermo Fisher 
Scientific). Data were accepted with an R2 value of 0.99 or above.  
All extracts were amplified using the GlobalFiler® PCR Amplification Kit (Thermo 
Fisher Scientific) with a target of up to 1 ng for 29 cycles or up to 0.5 ng for 30 cycles 
(when 1 ng was not available with maximum input volume) as per manufacturers’ protocol 
on a ProFlex™ PCR System (Thermo Fisher Scientific) (49). Separation and detection of 
amplified products was performed using the 3500 Genetic Analyzer (Thermo Fisher 
Scientific) with a 36-cm capillary and POP-4 polymer (Thermo Fisher Scientific). DNA 
profiles were generated using GeneMapper ID-X v4.1 software (Thermo Fisher Scientific) 
with an analytical threshold of 150 relative fluorescent units (RFUs) and stochastic 
threshold of 600 RFUs.  
Secondary Processing 
Samples from Phase 2 that did not produce a full STR profile (n=12) were subjected 
to secondary processing strategies as outlined in Appendix Figure B1 in an attempt to 
increase the number of reportable alleles. Method A: the remaining DNA eluates from 
replicate extractions were pooled in a single tube (approx. 70-90 µL) and concentrated in 
a CentriVap® Concentrator (Labconco, Kansas City, MO) for 25 min at 50°C to reduce the 
final volume to ~30-50 µL. Method B: duplicate bone chips that were previously digested 
separately were combined in the same tube, manually crushed with a disposable pestle (if 
possible), and re-digested and extracted manually with the PrepFiler® BTA™ Forensic 
DNA Extraction Kit (Thermo Fisher Scientific). DNA quantification and STR 





Parametric assumptions were tested for using a Shapiro-Wilk’s W test. Data were 
tested for statistical significance by Student’s t-test in Excel or ANOVA single or multi-
factor, followed by Tukey HSD post hoc comparisons in Statistica (50) when appropriate. 
p < 0.05 was accepted as the level of significance.  
Results and Discussion 
Phase 1 - DNA Yield and STR Profile Quality 
The two sets of bones used in this phase were selected to represent those within the 
upper and lower range of sample quantity and quality that might be observed in human 
remains recovered for identification. Due to the large inherent differences between the 
samples with high amounts of DNA (> 5 ng/μL) with moderate degradation (degradation 
index (DI) 3 – 11), and those samples with low amounts (< 0.02 ng/μL) with slight 
degradation on average (DI < 5), data for each was grouped and analyzed separately.    
For the high quantity samples, average DNA concentrations ranged from 
approximately 8 ng/μL (1x50 mg bone chip) to 24 ng/μL (150 mg bone powder) (Fig. 
3.2A). As determined by a Shapiro-Wilks W test, quantification data met the parametric 
assumption (p(normal) > 0.05)) for ANOVA statistical tests. A single factor ANOVA 
determined there to be a statistically significant difference between the sample types (F4,70 
= 39.4333, p = 0.0000) so a post hoc analysis was performed. Both 50 mg of bone powder 
and a 50 mg bone chip yielded comparable DNA concentrations and likewise, 150 mg of 
bone powder and three 50 mg bone chips (150 mg total) produced similar DNA 
concentrations. As expected, the 150 mg samples produced significantly more DNA than 
the 50 mg samples (p < 0.001). However, although the average DNA concentration for the 
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single 150 mg bone chips was significantly higher than the 50 mg bone samples (p < 0.05), 
it was significantly lower (p < 0.001) than the other 150 mg sets (150 mg powder and 3x50 
mg chips). These data may suggest that digestion of bone chips can be an efficient 
alternative to powdering without compromising DNA yields, and that multiple smaller 
chips may digest more effectively than one large 150 mg chip.  
 
FIG. 3.2 - Comparison of DNA concentration and STR profile results for Phase 1 based 
on the sample type and mass used for extraction (n=15 per sample type/mass). A) average 
DNA concentration for the high quantity samples; B) average STR profile completeness 
for the high quantity samples; C) average DNA concentration for the low-template 
samples; D) average STR profile completeness for the low-template samples. Error bars 
denote 0.95 confidence interval. * p < 0.05; ** p < 0.01; *** p < 0.001 (NOTE: not all 






With the exception of the 150 mg powder set, STR data met the parametric 
assumption for ANOVA statistical tests as determined by a Shapiro-Wilks W test 
(p(normal) > 0.05)), and therefore it was deemed reasonable to proceed with the analysis. 
The average percent of alleles reported ranged from 86% (50 mg bone chips) to 95% (150 
mg bone powder) (Fig. 3.2B). Despite the variance in DNA concentration, no significant 
difference in STR success was observed between any of the sample types as determined by 
a single factor ANOVA (F4,40 = 1.1780, p = 0.3351). In addition, single factor ANOVAs 
determined that the incubation time (2, 4, or 16 hrs) had no statistically significant effect 
on DNA concentration (F2,72 = 1.3629, p = 0.2624) (Appendix Fig. B2A) or reportable 
alleles (F2,42 = 0.3631, p = 0.6977) (Appendix Fig. B2B) for powdered or whole bone chips 
(p > 0.05).   
Results from the low-template sample showed some different trends to the bone 
samples containing more DNA. Average DNA concentrations ranged from approximately 
0.002 ng/μL (50 mg bone chip) to 0.01 ng/μL (150 mg bone powder) (Fig. 3.2C). Although 
parametric assumptions were not met in some cases (50 mg and (3) 50 mg bone chip sets) 
as determined by a Shapiro-Wilks W test (p(normal) < 0.05), it was deemed reasonable to 
proceed with ANOVA statistical analyses. As with the previous data set, a single factor 
ANOVA determined that there was a statistically significant difference between the sample 
types (F4,70 = 26.1719, p = 0.0000), and therefore a post hoc analysis was performed. Both 
sets of powdered samples (50 and 150 mg) had higher average DNA concentrations than 
the three bone chip sets, and 150 mg of bone powder still yielded significantly more DNA 
than 50 mg powder (p < 0.001). However, all bone chip sets (50 mg, 3x50 mg, 1x150 mg) 
performed similarly regardless of bone mass (p > 0.05). These data suggest that for bone 
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samples containing very little DNA, a difference in bone chip number and/or mass may not 
have an effect on DNA recovery, and that powdering remains the more successful method.  
Unlike the high quantity sample set, allele recovery significantly differed between 
sample types (F4,70 = 42.7478, p = 0.0000). Although parametric assumptions were not met 
in some cases (50 mg and 150 mg bone powder sets) as determined by a Shapiro-Wilks W 
test (p(normal) < 0.05), it was deemed reasonable to proceed with ANOVA statistical 
analyses. The overall trend for STR results (Fig. 3.2D) showed that the powdered sets 
produced a significantly higher percentage of reportable alleles than the bone chips (p < 
0.001). This result is not unexpected as more DNA was available for amplification with 
the powdered samples. However, all bone chip sets yielded comparable numbers of 
reported alleles with a range of approximately 42-46% (p > 0.05), and both powdered sets 
performed similarly with an average of 86-93% alleles (p > 0.05). As with the high quantity 
sample set, incubation time had no effect on DNA concentration (F2,72 = 0.2369, p = 
0.7897) (Appendix Fig. B2C) or reportable alleles (F2,72 = 0.7261, p = 0.4873) (Appendix 
Fig. B2D) (p > 0.05). 
Overall for both sets of samples, there was no single combination of chip weight 
and incubation time that was significantly better than the others for DNA concentration 
and/or allele recovery (Appendix Fig. B3). Therefore, as none of the variations in bone 
chip number/size or increase in incubation time tested in this study generated significantly 
better results than the manufacturer’s recommendations for powdered bone (50 mg bone, 





Phase 2 - DNA Yield  
Bone tissue was taken from 20 environmentally challenged bones (Table 3.1), and 
DNA was extracted from a single 50 mg bone chip in duplicate with the PrepFiler® BTA™ 
Forensic DNA Extraction Kit automated on the Automate Express™ platform (Thermo 
Fisher Scientific) following a 2 hour incubation. Five partial tooth fragments were also 
processed in this manner, but without replicates due to the availability of only a single 
fragment. With the exception of the tooth fragments, DNA from 50 mg of powdered bone 
was also extracted manually with both a total demineralization method and commercial 
DNA extraction method (PrepFiler® BTA™ Forensic DNA Extraction Kit) to serve as 
control groups for the bone samples. 
Normalized DNA concentrations ranged from 0 to 35.8 ng/mg of bone for bone 
chips (Appendix Fig. B4) and from 0.0009 to 23.4 ng/mg of tooth fragment (data not 
shown) when extracted with PrepFiler® BTA™ chemistry on the AutoMate Express™. A 
femur sample from a body cremated in an outdoor fire pit did not yield a quantifiable 
amount of DNA with any of the DNA extraction methods tested, and was therefore 
removed from further analysis. This result was not unexpected as the sample was extremely 
burnt and very brittle. Overall, powdered samples extracted manually yielded slightly more 
DNA on average than bone chips (5.0 ± 1.6 ng/mg bone vs 3.0 ± 1.1 ng/mg bone), but this 
difference was not statistically significant (p > 0.05) (Fig. 3.3A). Additionally, no statistical 
difference in DNA yield was observed between the two manual methods (Fig. 3.3B), 
suggesting that PrepFiler® BTA™ may be just as effective at extracting DNA from 50 mg 
of powdered bone compared to the more time-consuming total demineralization method. 
These results are consistent with previous work comparing the same two traditional 
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powdering methods with a non-powdering method (34). As determined by the IPC ∆CT 
during DNA quantitation, no inhibition was detected in any samples, and negative controls 
showed no signs of contamination. 
 
FIG. 3.3 - Comparison of average normalized DNA concentrations for the first round of 
DNA extractions in Phase 2 with the powdered samples: A) combined in the sample type 
(n=20 each) and B) separated by DNA extraction method (n=10, n=10, n=20, 
respectively). Error bars denote the standard error of the mean (SEM). 
 
Although comparable in yield, DNA extracted from bone chips was more degraded 
on average compared to DNA recovered from powdered bone (7.4 ± 1.4 vs 4.2 ± 0.4; p < 
0.05) as determined by the DI from Quantifiler® Trio. This could be due to the BTA™ 
buffer only having access to the surface and limited porous areas of the chip, which was 
subject to damaging heat during the sanding and cutting process and several aggressive 
cleaning steps, while the cells and crystal aggregates at the core of the chip are more 
protected, and then released during the powdering process (7, 35, 39). In general, samples 
from the embalmed and decomposed cadavers showed the highest degradation levels on 
average, with DIs ranging from approximately 1.9 to 17.5. 
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As methods to extract DNA from bones are being modified and improved, several 
studies have investigated the use of skeletal elements other than the more traditionally 
harvested femur, tibia, and humerus for the identification of human remains (6, 11, 18, 21, 
22, 27, 29-31). In this study, non-traditional elements (radius, ulna, rib end, vertebral 
transverse process, broken tooth fragments, and hand and foot phalanges) yielded slightly 
higher concentrations and less degraded DNA (p > 0.05), and resulted in significantly more 
alleles reported (p < 0.01) compared to traditional bony elements (Fig. 3.4). The three bone 
chips that yielded the highest concentrations of DNA per 50 mg of bone tissue across the 
entire study were from a vertebral transverse process, a maxillary canine fragment, and a 
femur with 35, 23, and 21 ng DNA/mg bone, respectively. Except for a single replicate, all 
bone chips from non-traditional elements resulted in STR profiles with greater than 70% 
alleles called. Although results from other studies differ in their rankings of the most 
successful bones, non-traditional bony elements, especially those from the hands and feet, 
have ranked similarly or better than femurs and teeth (6, 11, 21, 22). Therefore, DNA can 
be effectively recovered from many different bony elements using this non-powdering 
method and laboratories should also consider extracting DNA from bony elements other 
than more traditional sources. In some cases, those weight-bearing long bones may not 




FIG. 3.4 - Comparison of DNA extract and STR profile metrics between traditional (n=24) 
and non-traditional (n=21) skeletal elements in Phase 2. Traditional elements include: 
humerus, femur, tibia; Non-traditional elements include: teeth, radius, ulna, rib ends, hand 
and foot phalanges. Error bars denote the standard error of the mean (SEM). **p < 0.01 
 
Phase 2 - STR Profile Quality 
In total, at least one of the replicate chips from six bone samples (Appendix Fig. 
B5) and three out of five tooth fragments (data not shown) resulted in full GlobalFiler® 
STR profiles. However, if only analyzing the 20 expanded core CODIS loci, then eight of 
the bone samples yielded full profiles from a single 50 mg chip. Most of these samples had 
high quantities of DNA and low to moderate degradation indices as determined by 
Quantifiler® Trio. With the exception of one sample, STR results from replicate chips 
varied by less than 10% reportable alleles, which shows that while there is natural variation 
between sequential bone chips, results are generally reproducible. One set of bone chips 
from a rib end from a buried cadaver failed to amplify despite showing DNA 
concentrations ranging from 0.016 to 0.076 ng/μL, a DI of 49.6 to 2.9, and no inhibition 
(IPC ∆CT = 0.16 and -0.04, respectively). However, DNA extracted from powder of that 
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same sample yielded similar quantification results but near complete STR profiles. 
Therefore, the authors hypothesized that the soil on the bone chips was not effectively 
removed during the cleaning and/or DNA extraction processes and as soil is a known 
source of the inhibitor humic acid, inhibition may have caused the failed amplification. In 
an effort to rescue these failed samples, the DNA extracts from the bone chips were diluted 
1:2 in an attempt to reduce the effects of inhibition, but they still failed to amplify any 
alleles. Unfortunately, the remaining pieces of the rib end were consumed during 
powdering, so the bone could not be re-sampled and was therefore removed from further 
analyses.  
Average peak heights were comparable between the two sample types (2318.8 ± 
333.3 RFUs for bone chips vs 2707.6 ± 262.1 RFUs for bone powder), but STR profiles 
from bone chips were less balanced than the powdered samples with average heterozygous 
peak heights of 49.3 ± 5.1% vs 65.7 ± 2.5% (p < 0.01). Average allele recovery for bone 
chips was also lower than the powdered samples (71.5 ± 5.3% and 93.1 ± 1.7% 
respectively; p < 0.001). An increase in the level of degradation and slightly less DNA 
available for amplification are likely strong factors for this difference, as 66% of alleles 
that dropped out for bone chips, and 86.7% for powdered samples, were at loci with larger 
amplicon sizes (> 200 bps). With the long target of Quantifiler® Trio being only 214 bps, 
the predictability of alleles amplified at these longer loci might not be as easily apparent 
based on small amplicon input or degradation values alone (Appendix Fig. B6). Indeed, we 
observed a general trend that as the amount of long amplicon DNA into PCR increases 
(based on the amount of short amplicon added), the percentage of alleles reported increases 
in a logarithmic manner (Appendix Fig. B7). The lowest amount of long amplicon DNA 
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in the PCR reaction that resulted in a full STR profile was 0.05 ng. This sample had a DNA 
input of 0.35 ng based on the short amplicon quantity and a DI of 7.  
Phase 2 - Secondary Processing Strategies 
With 6 of the 20 bone samples having full STR profiles and two samples being 
excluded from further study, the remaining 12 sets of bone chips were subjected to further 
testing using two approaches: A) pooling and concentrating DNA elutes of duplicate bone 
chips, and B) combining the replicate bone chips remaining intact after the first round of 
extraction and subjecting them to a second round of extraction.  
As expected, when DNA extracts were pooled and concentrated, the DNA 
concentration increased (approx. 2.5–fold increase) (Fig. 3.5). However, an improvement 
in allele recovery was only observed in half of those re-worked samples, with an average 
increase of approximately 10% in the number of reportable alleles compared to the first 
extraction of the bone chip on the Automate Express™ (Fig. 3.5; Appendix Fig. B8). The 
six samples that showed improvement had < 100 pg in the original PCR, but the new input 
amount provided approximately twice the amount of DNA for amplification. Pooled 
eluates were concentrated to approximately 30 μL, so further concentration may have 
resulted in even greater allele recovery.  
Combining duplicate bone chips (from the first round of extractions) into a single 
sample digestion tube and re-extracting manually with the PrepFiler® BTA™ kit showed 
no increase in the recovery of DNA or improvement in the number of reportable alleles 
(Fig. 3.5). As similar amounts of DNA as the first extraction were obtained, this strategy 
does offer the possibility to re-exact from the original bone chip if needed. An analyst also 
potentially could recover more DNA by performing subsequent rounds of extractions for 
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further pooling and concentration; however, this approach would be more time consuming 
and increases the risk of contamination due to multiple rounds of sample handling. When 
compared to the original automated extraction of bone chips, and regardless of the 
secondary strategy employed, the manual extraction from bone powder (control method) 
was still the most successful (p < 0.01) processing approach overall (Fig. 3.5). For samples 
yielding incomplete STR profiles on the first-pass, an improvement in allele recovery for 
all twelve reworked samples was observed, with four of those samples resulting in full STR 
profiles (Appendix Fig. B9). 
 
FIG. 3.5 - Comparison of average A) DNA concentration and B) STR alleles reported for 
each of the processing strategies in Phase 2. ** p < 0.01; *** p < 0.001 
 
 Conclusions 
Many different protocols for processing and extracting DNA from bones and teeth 
are used in various laboratories across the world. These methods are almost exclusively 
performed manually and require bone samples to be powdered, making them time-
consuming and requiring specialized equipment and technical training. Therefore, many 
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crime laboratories may choose to outsource these samples. However, this study has shown 
that the PrepFiler® BTA™ extraction kit can perform similarly to other commonly used 
DNA extraction protocols for bone tissue that are more time-consuming and require 
reagent preparation (4, 14, 23, 34, 47). The results of this study have also demonstrated 
that the PrepFiler® BTA™ kit can effectively extract DNA from whole bone chips without 
having to powder the samples. This non-powdering method using a commercial kit may 
make it a more attractive option for crime laboratories to process their own bone samples 
if they already have this chemistry integrated into their current workflow. In this study, the 
PrepFiler® BTA™ buffer appears to digest whole bone chips equally effectively as 
powdered bone for a variety of skeletal samples. While 3x50 mg bone chips produced 
better results in some cases, overall a single 50 mg chip yielded comparable results in DNA 
concentration and STR success. Neither an increase in incubation time (2, 4, or 16 hrs) nor 
bone chip mass (50 - 150 mg) and/or number (1 - 3 bone chips) significantly improved 
results compared to the current manufacturer’s recommended protocol for powdered bone 
(50 mg powder for 2 hrs) with the standard buffer volume. Therefore, these data suggest 
that no further optimization of these conditions would be required in order to successfully 
process whole bone chips (in lieu of bone powder) using this chemistry. 
In the phase 2 study, over a third of the bones sampled resulted in a full profile (all 
CODIS loci) in the first-pass from a single 50 mg chip processed using the PrepFiler® 
BTA™ chemistry on the AutoMate Express™ platform. Bone powder and chips of similar 
weight performed comparably in the resultant DNA concentration and STR success in most 
cases, but data also showed that a non-powdering extraction may not be as efficient as 
powdering bone prior to digestion for highly compromised or bone samples with very little 
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DNA. However, the bone chip approach presents a possibility for a quick triaging 
approach, or for additional extractions to be performed from the same bone chip to improve 
or supplement DNA recovery without consuming more of the original bone sample. If 
desired, the chip could be rinsed, powdered, and then undergo a subsequent extraction. 
Overall, this study has shown that full STR profiles can be quickly recovered from 
contemporary whole bone chips and broken tooth fragments using a commercial DNA 
extraction kit and an automated workflow without having to crush the sample into a fine 
powder. Furthermore, DNA quantity and quality from any bone sample submitted as 
evidence may be screened in-house before (or avoid) having to perform longer, more labor-
intensive manual protocols, or outsource to specialized labs for processing. 
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When samples with low amounts of DNA are amplified using Short Tandem 
Repeats (STRs), stochastic effects such as allele and locus dropout or drop-in, allele 
imbalance, and increased stutter often occur making data interpretation more difficult. The 
most common approach to improving STR results from low template samples is to increase 
the number of PCR cycles. Although more alleles may be recovered, stochastic effects may 
be exaggerated resulting in more complicated STR profiles. This work reports the effect of 
additional PCR cycles (29 vs. 30, 31, and 32) on STR success from environmentally 
challenged bone and tooth samples using the GlobalFiler® DNA amplification kit (Thermo 
Fisher Scientific). In addition, we compared the efficiency of two DNA extraction kits for 
skeletal samples: QIAamp® DNA Investigator (QIAGEN) and PrepFiler® BTA™ Forensic 
DNA Extraction (Thermo Fisher Scientific) kits. Results showed that more DNA was 
recovered from samples using the PrepFiler® BTA™ kit, but regardless of the extraction 
method the number of alleles detected and the peak heights both increased with an increase 
in PCR cycle number. Although more alleles were reported in almost all samples, the most 
notable improvement was observed in samples with the DNA template <120 pg. A general 
increase in the number of PCR artifacts was detected in STR profiles generated using 30-
32 cycles. Overall, this study provides supporting evidence that STR profile completeness 
and quality may be improved when low template skeletal samples are amplified with extra 
PCR cycles (up to 32 cycles) using the GlobalFiler® DNA amplification kit. 
 
Keywords:  low-template DNA; skeletal; low-copy number; GlobalFiler® 
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The effects of extra PCR cycles when amplifying skeletal samples with the 
GlobalFiler® PCR Amplification Kit 
Introduction 
Many types of forensic evidence such as blood stains and buccal swabs provide 
abundant amounts of nuclear DNA for forensic analysis and provide robust and reliable 
genotyping of individuals with high discriminatory power (1). However, some biological 
samples submitted to forensic laboratories prove to be more challenging. In the case of 
mass disasters, missing persons’ cases, severe fires, and mass graves, skeletonized remains 
(bone and teeth) may be the only elements available for human identification (2-6). When 
performing STR analyses from bone samples, several difficulties may arise due to DNA 
damage, fragmentation, and/or very low amount of DNA available for amplification. These 
conditions may result in the loss of loci and increase of undesired PCR artifacts due to 
stochastic effects during amplification. These artifacts must be taken into consideration 
when genotyping difficult skeletal samples, as they can complicate data interpretation.  
Several approaches have been proposed to improve the results from low template 
DNA (LT-DNA) bone samples (4, 5, 7-19), including optimizing DNA extraction methods 
for skeletal samples (2, 4, 5, 20, 21). For LT-DNA samples in general, another strategy to 
increase the number and confidence of the alleles reported is to generate a consensus 
profile. This process involves splitting a single DNA extract into multiple PCR reactions 
and only reporting alleles when observed more than once (4, 7, 10, 13, 19, 22-27). 
However, debate exists whether this splitting approach generates better results than with a 
single amplification (19, 23-27). Nevertheless, the most common strategy to recover more 
complete STR profiles from LT-DNA samples is to increase the number of cycles during 
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PCR amplification, a process termed high sensitivity (10, 22, 28) or low copy number 
(LCN) typing (5, 8, 10, 12-15, 18, 19, 28). Although varying levels of success using these 
LCN-typing techniques has been reported (5, 7-10, 12-15, 18, 22, 28, 29), the robustness 
and reliability of results from LCN typing has also been a subject of scrutiny (7, 8, 22, 28-
31). PCR artifacts such as allele drop-in, heterozygous peak height imbalance or 
exaggerated stutter may be more severe (7-10, 14, 15, 19, 22, 28). This work documents 
the effect of additional PCR cycles when using the GlobalFiler® DNA amplification kit to 
genotype bone and tooth samples. 
Materials and Methods 
Sample Preparation  
Bone and tooth samples (n=12) were collected from 11 cadavers exposed to various 
environmental insults at the Applied Anatomical Research Center (AARC) at Sam Houston 
State University, Huntsville, Texas, USA (Appendix Table C1). The surface (1 mm) of 
each bone was sanded to remove any contamination and cut into small pieces (3-5 mm2) 
using a Dremel tool (Dremel, Racine, WI, USA) before being washed with a series of 5 
min washes: 15% bleach, two washes of autoclaved distilled water, and 70% ethanol. The 
samples were dried overnight. Bone samples were crushed into a fine powder in a SPEX 
6750 liquid nitrogen Freezer-mill (SPEX SamplePrep, Metuchen, NJ). An extraction blank 
was prepared by wetting a cotton swab with sterile water and swabbing the inside of an 
empty Freezer-mill tube each batch. 
DNA Extraction and Quantification 
Bone powder (100 mg) from twelve bone samples were extracted in duplicate using 
two methods; 1) QIAamp® DNA Investigator Bone and Teeth protocol (QIAGEN, Hilden, 
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Germany) with a 40 μL elution volume (32), and 2) PrepFiler® BTA™ Forensic DNA 
Extraction Kit Bone and Tooth protocol (Thermo Fisher Scientific, Carlsbad, California, 
USA).  The PrepFiler® kit extraction was performed using two aliquots of 50 mg of powder 
and an 18 hr lysis incubation at room temperature as recommended (33). The two neat 
elutes from the PrepFiler® extractions (50 mg powder) were pooled to provide a total 
extract volume of 100 μL from 100 mg of bone powder. A reagent blank was run in parallel 
with both extraction procedures to monitor contamination. DNA reference samples were 
available for all cadavers. 
The amount of DNA in each sample extract (n=48) was determined via quantitative 
real-time PCR (qPCR) using the Quantifiler® Trio DNA Quantification kit (Thermo Fisher 
Scientific) as per manufacturer’s instructions (34). Data were accepted with an R2 value of 
0.99 or above.  
STR Typing and Data Analysis 
A selection of 30 DNA extracts under 0.03 ng/μL were amplified in a 25 μL 
reaction volume using the GlobalFiler® PCR Amplification Kit (Thermo Fisher Scientific) 
with 29, 30, 31, and 32 cycles on a ProFlex™ PCR System (Thermo Fisher Scientific) (35). 
No template controls were included to monitor contamination. Separation and detection of 
amplified products was performed on the ABI Prism 3500 Genetic Analyzer (Thermo 
Fisher Scientific). DNA profiles were generated using GeneMapper ID-X v4.1 software 
(Thermo Fisher Scientific) with an analytical threshold of 150 RFUs and stochastic 
threshold of 600 RFUs being applied. Loci with a single peak below the stochastic 
threshold of 600 RFUs were considered a high potential for allele drop-out, and as such 
only one allele was reported at that locus.  
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Data were tested for statistical significance by Student’s t-test in Excel or ANOVA 
single factor followed by Tukey HSD post hoc comparisons in Statistica (36) when 
appropriate. p < 0.05 was accepted as the level of significance. 
Results and Discussion 
DNA Quantitation 
When comparing overall DNA yields, significantly more DNA (p = 0.018) was 
recovered from 100 mg of bone and tooth samples using the PrepFiler® BTA™ Forensic 
DNA Extraction kit than the QIAamp® DNA Investigator kit (average yield of 1486.3 ± 
551.7 ng compared to 117.9 ± 49.7 ng per 100 mg bone powder). This difference in DNA 
yield could potentially be due to the smaller amount of starting material for the PrepFiler® 
samples (2 x 50 mg powder) compared to a single batch of 100 mg of powder with the 
QIAamp® DNA Investigator protocol. Previous studies have shown that using less bone 
powder per extraction may increase the total yield of DNA due to the ability of EDTA to 
more efficiently break down the hydroxyapatite matrix and complex the resulting calcium 
ions (2, 20, 21). In addition, the use of silica spin columns during the Investigator extraction 
(compared to silica-coated magnetic beads in the PrepFiler® kit) may have also contributed 
to the loss of DNA using this method. Several studies have reported significant loss of 
DNA when spin columns are used for DNA purification as DNA, especially smaller 
fragments, may be retained on the silica membrane after elution (37-40).  
An additional benefit of the PrepFiler® BTA™ kit is that the sample stays in the 
same tube during the entire bind, wash, and elute process which may minimize the 
contamination risk and sample loss due to changing tubes and increased sample 
manipulation. Although the overall DNA yield was significantly different between the two 
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methods, the extraction method did not have a significant effect on the level of DNA 
degradation (p = 0.08), as measured by the degradation index (DI) in this study. No PCR 
inhibition was observed in any extracts, and all negative controls/reagent blanks showed 
no signs of DNA contamination. 
STR Typing 
The DNA concentrations of the 30 samples tested in the cycling study ranged from 
0.0006 to 0.03 ng/μL of DNA. The total amount of DNA amplified in each PCR reaction 
therefore ranged from 0.009 to 0.45 ng (up to 15 μL input). STR data is displayed in Fig. 
4.1 A-D, while data normalized in relation to the average 29 cycle data can be seen in 
Appendix Figure C1a-d. In general, the number of reportable alleles increased when 
additional PCR cycles (30-32 versus 29 cycles) was used (Fig. 4.1 and Appendix Fig. C1a). 
For data analysis, samples were placed into one of five groups based on the amount of 
DNA in the PCR: <30 pg (n=4), 30-60 pg (n=5), 60-120 pg (n=6), 120-200 pg (n=6), and 
200-500 pg (n=9), where 120 pg appears to denote a notable difference in STR success 
based on the amount of DNA amplified (Appendix Fig. C2).    
A one-way ANOVA determined that there was a significant difference in the 
number of reportable alleles for the <30 pg (F3,12 = 3.490, p = 0.0498), 30-60 pg (F3,16 = 
3.239, p = 0.0002), and 60-120 pg (F3,20 = 3.098, p = 0.015) groups, so a post hoc analysis 
was performed for each group. For samples with less than 30 pg of input DNA, the average 
number of reportable alleles significantly increased (p < 0.05) from 10.9 ± 3.4 % with 29 
cycles to 64.1 ± 16.3 % with 32 cycles (Fig. 4.1A). For samples with 30-60 pg of input 
DNA, the average number of reportable alleles significantly increased (p < 0.05) from 28.0 
± 3.3 % with 29 cycles to 54.7 ± 9.4 % with 31 cycles and 80.3 ± 3.6 % with 32 cycles (p 
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< 0.001) (Fig. 4.1A). Finally, for samples with 60-120 pg of input DNA, the average 
number of reportable alleles significantly increased (p < 0.05) from 32.5 ± 6.0 % with 29 
cycles to 71.3 ± 6.5 % with 32 cycles (Fig. 4.1A). Although the increase in reportable 
alleles was not deemed to be significant by one-way ANOVA for the 120-200 pg and 200-
500 pg groups, the number of samples with full profiles more than doubled (3 to 7 samples) 
with the addition of a single cycle and tripled (3 to 9 samples) with the addition of three 
cycles. As shown in other studies (7, 12-14), the addition of even more cycles may result 
in an even larger increase in STR success and number of full profiles. However, the more 
PCR cycles that are added, the more likely stochastic effects will be exaggerated, further 
complicating data interpretation.   
Contrary to other studies using additional PCR cycles (7, 9, 14), a significant 
difference (F3,16 = 3.239, p = 0.002) in average peak height ratio (APHR) was only 
observed for the 30-60 pg group rather than all samples tested (Fig. 4.1B). There was a 
significant improvement in APHR when amplified with 32 cycles (37.8 ± 2.6%) compared 
to 29, 30, and 31 cycles (10.4 ± 1.0% (p < 0.01), 18.1 ± 4.7% (p < 0.05), and 19.6 ± 6.5% 
(p < 0.05) respectively) (Fig. 4.1B and Appendix Fig. C1b). However, all samples 
amplified with <120 pg at 29, 30, 31 and 32 cycles generated imbalanced profiles (less 
than 50% APHR). When samples with >120 pg were amplified, peak balance was 
acceptable (55 – 67%), and additional PCR cycles did not improve amplification balance. 
As expected, significantly higher average peak heights (APH) were observed in all groups 
when amplified with 32 cycles than with 29 cycles (p < 0.05) (Fig. 4.1C and Appendix Fig. 
C1c). Increase in fluorescence ranged from an average of 29.7 ± 8.7 RFUs to 639.9 ± 251.3 
115 
 
RFUs for the <30 pg group to an average of 968.9 ± 180.1 RFUs to 6968.4 ± 1177.2 RFUs 
for the 200-500 pg group (Fig. 4.1C).   
FIG. 4.1 - Comparison of STR profile quality between the different sample groups 
categorized by template amount (n=4, n=5, n=6, n=6, and n=9, respectively) and cycle 
number based on (A) percentage of correct alleles reported; (B) average peak height ratio; 
(C) average peak height; (D) average number of observed PCR artifacts per profile 
(exaggerated stutter, off-ladder alleles, drop-in alleles, pull-up origins, and incomplete 
adenylation). Data is presented as average + standard error of the mean (SEM). *p < 0.05, 
**p < 0.01 
 
Consistent with other studies (7, 9, 15), we also observed an increase in the 
occurrence of exaggerated stutter peaks and other artifacts when samples were amplified 
with additional PCR cycles (Fig. 4.1D). It should be noted that most of these artifacts were 
observed in samples with more than 200 pg of input DNA, especially when amplified with 
32 cycles (Fig. 4.1D and Appendix Fig. C1d). A summary of these artifacts can be seen in 
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Appendix Table C2. The most commonly observed artifacts were elevated stutter and pull-
up events. For the majority of additional stutter peaks reported, the -8 stutter allele was 
called while the -4 stutter allele was visually present, but not reported because it fell under 
the stutter filter threshold. In this study, the D22, D3, D5, and SE33 markers showed the 
highest occurrence of elevated stutter peaks (Appendix Table C2). Additionally, two 
occurrences of incomplete adenylation were observed in two samples amplified with 32 
PCR cycles. The STR artifacts observed in this study did complicate the data interpretation, 
but did not prohibit analysis due to the availability of known reference profiles. However, 
it is important to note that for forensic casework samples and mixtures these artifacts will 
likely pose a more serious complication for data interpretation. 
Representative STR profiles from a sample (64 pg) amplified with 29, 30, 31, and 
32 cycles can be seen in Fig. 4.2 and Appendix Figure C3. As expected, increasing the 
cycle number had the greatest influence on peak heights and the number of artifacts 
observed for samples with a larger DNA input, and greater increases in reportable alleles 
and peak height ratios for those with lower DNA inputs. In general, for samples with <120 
pg of input DNA (n=15), the percentage of reportable alleles was significantly improved 
with each additional PCR cycle (30-32 cycles) while APH, APHR, and the number of 
artifacts were only elevated with 32 cycles. For samples with 120-500 pg of input DNA (n 
=15), the percentage of reportable alleles, APH, and number of artifacts were improved or 







FIG. 4.2 - Example of electropherograms and comparative STR data for a buried humerus 




Significantly more DNA was recovered from all bone and tooth samples using the 
PrepFiler® BTA™ Forensic DNA Extraction kit than the QIAamp® DNA Investigator kit. 
However, regardless of the extraction method, consistently more alleles were recovered 
from low-template skeletal samples with the addition of extra PCR cycles using the 
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GlobalFiler® PCR Amplification Kit with minimal adverse STR artifacts in samples 
amplified with up to 32 cycles. As expected, the improvement observed in STR profile 
quality with additional PCR cycles was most pronounced in low template samples (<120 
pg DNA). At the time of this study, no publications have specifically reported the 
effectiveness of using additional PCR cycles to genotype low template or skeletal samples 
with the GlobalFiler® PCR amplification kit. Overall, this study provides supporting 
evidence that STR success may be increased in low template bone and tooth samples with 
the addition of extra PCR cycles (up to 32 cycles for less than 120 pg of input DNA and 
up to 31 cycles for 120-500 pg of input DNA) using the GlobalFiler® PCR amplification 
kit with minimal effect on data interpretation. With the inherent variability in DNA 
quantity and quality in skeletal samples, results may differ from laboratory to laboratory 
and sample to sample; therefore, a thorough internal validation and data interpretation 
training is necessary before applying these modifications to any type of casework samples. 
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Forensic DNA laboratories may process database reference samples on FTA® cards 
or buccal swabs, which commonly contain adequate amounts of quality DNA for full STR 
profiles and high first-pass rates. However, some reference samples and many forensic 
casework samples may be exposed to a variety of insults that may lead to low quantities of 
DNA, DNA degradation, DNA mixtures, and/or PCR inhibition, which can pose 
challenges to downstream genotyping success. The inclusion of multiple targets and 
internal PCR controls (IPCs) in DNA quantification kits and quality sensors within STR 
amplification kits can aid in the accurate interpretation of sample/profile quality, and guide 
more efficient rework strategies when needed.  
In order to assess the effectiveness of these quality systems we subjected database-
like samples (buccal swabs and blood or saliva on FTA® cards), mock casework samples 
(low-template, degraded, inhibited, DNA mixtures), and authentic post-coital samples to 
various challenging conditions. Concordance between the quality flags in the Investigator® 
Quantiplex® Pro RGQ kit (QIAGEN), the QS markers in QIAGEN’s Investigator® 24plex 
QS kit, and overall STR profile quality was evaluated for all casework-type samples. To 
assess the value of the QS markers in the Investigator® 24plex QS and GO! STR kits, 
samples with partial or failed STR profiles were reworked based on the quality of the 
electropherogram 1) with the QS markers redacted, and 2) in conjunction with the QS 
markers. Results from each of the rework approaches were compared to determine which 
strategy, if any, improved the STR profile quality and the number of reportable alleles.  
Overall, the processing of challenged database and mock casework samples 
resulted in a wide range of quantification data (when applicable) and STR success 
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depending on the type of sample. The QS markers in the 24plex STR kits correctly 
confirmed sample quality in 99.9% of databasing samples and 98.4% of mock casework 
samples. Quality flags during DNA quantification were concordant with the STR profiles 
for the majority (77%) of the mock casework samples. Additionally, when samples with 
partial STR profiles were reworked, more complete profiles were obtained for 80% of the 
samples regardless of the rework strategy used. However, the most notable improvement 
in STR completeness was observed in inhibited samples that were reworked based on the 
information provided by the STR quality sensors, with an average increase of 56% 
reportable alleles. 
 
Keywords: forensic science; DNA; challenging samples; Investigator Quantiplex Pro 
RGQ; Investigator 24plex QS; Investigator 24plex GO!; QS markers; rework strategies   
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The performance of quality controls in the Investigator® Quantiplex® Pro RGQ and 
Investigator® 24plex STR kits with a variety of forensic samples 
Introduction 
While many samples submitted for analysis have ample amounts of DNA available 
for STR typing and produce complete STR profiles, forensic analysts still encounter 
reference and casework samples that fail or result in incomplete profiles. Common 
challenges include PCR inhibition (1-3), DNA degradation (4-6), DNA mixtures (7-9), and 
low amounts of DNA (10-13). Sources of PCR inhibition can be from the 
collection/preservation method, the substrate, environment, or the sample itself. 
Endogenous hematin in blood (1-3, 14) and EDTA (3) from blood collection tubes and in 
FTA® cards are common sources of PCR inhibitors in blood samples submitted to forensic 
agencies for DNA analysis. With buccal swabs, poor collection techniques may result in 
inadequate amounts of cells being collected and transferred to the swab and/or paper, and 
exogenous inhibitors from food and beverages (3) can interfere with STR typing.  
Forensic DNA quantification and STR kits are designed to be both sensitive to low 
amounts of DNA and tolerant enough to overcome many common inhibitions for a wide 
range of forensic samples. However, when they do fail, samples often need to be reworked 
in order to generate the most probative DNA result possible. To avoid multiple reworks, 
as much information about the sample quality and quantity should be known in order to 
make the most informed decision and apply the most appropriate strategy. For casework 
and some databasing samples that are processed with the traditional workflow of DNA 
extraction, quantification, amplification, and capillary electrophoresis (CE), sample quality 
and quantity information is provided during the quantification step. However, with 
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databasing samples that are processed using direct amplification without quantification, no 
quality metrics are known prior to STR typing (14-17). This lack of information can hinder 
profile interpretation when a sample fails to produce a complete or high quality STR 
profile, and can make rework determination difficult, especially with ambiguous, low-
level, partial and/or failed profiles. 
The Investigator® 24plex GO! and Investigator® 24plex QS kits are designed to 
amplify database and casework samples, respectively (18). In addition to the expanded 20 
CODIS core loci and three additional loci (Amelogenin, SE33, DY391), these STR kits 
also include two quality sensor targets within the purple dye channel (QS1 - 74 bp and QS2 
- 435 bp) (19, 20) that serve as an internal PCR control (IPC), similar to those included in 
many DNA quantification kits. The signal of the QS2 (‘S’) marker tends to markedly 
decrease in height (or drop out) with PCR inhibition, compared to the QS1 (‘Q’) (19, 20), 
except in the presence of extreme inhibitor concentrations when both markers fail to 
amplify. The presence/absence of one or both QS markers can often assist in differentiating 
STR profiles that are of poor quality due to PCR inhibition, DNA degradation, failed 
amplification or absence of DNA (18-23). Overall, the behavior of these quality sensors 
may simplify the interpretation of STR profiles and could direct analysts towards the most 
appropriate rework strategies (21-23). 
Investigator® Quantiplex® Pro RGQ is a DNA quantification kit that has been 
designed to run on a Rotor-Gene Q system (24, 25) and pair with downstream genotyping 
kits such as the Investigator® 24plex QS kit (25). It is a unique expansion of the 
Investigator® Quantiplex® Pro kit in that it includes a fifth target; an additional male target 
that indicates degradation of any male DNA in the reaction. This allows for the 
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simultaneous detection of human autosomal and Y-chromosomal degradation (24-27) 
while maintaining high sensitivity, especially for male DNA in the presence of high 
amounts of female DNA (e.g. post-coital vaginal swabs) (26), and the ability to monitor 
inhibition with its Internal Control (IC) (24-26). According to the manufacturer (28), the 
sensitivity of the Investigator® Quantiplex® Pro RGQ IC in the presence of PCR inhibitors 
mirrors that of the QS markers in the Investigator® 24plex QS kit. Therefore, the IC can be 
used to accurately predict the presence and influence of PCR inhibitors within a sample. 
Together, the quality flags in the RGQ kit and the QS markers in the 24plex STR kits 
should be consistent with each other and accurately reflect the quality of the sample and 
resultant STR profile. 
In this study, the performance of the Investigator® 24plex GO! and Investigator® 
24plex QS kits and their QS markers were tested against a wide range of high quality and 
challenged databasing and casework-type samples. The informativeness of the 
Investigator® Quantiplex® Pro RGQ kit quality controls were also assessed for a range of 
casework-like samples (low template, degraded, and inhibited single-source DNA extracts, 
mock and authentic DNA mixtures). Finally, we investigated any potential benefit in 
applying the information provided by the STR quality sensors when determining any 
subsequent rework strategy, to the interpretation of electropherograms (EPGs) with 
reduced profile completeness. Two approaches were taken: the first was to remove the QS 
marker information and have external analysts determine a rework strategy based solely on 
the STR profile quality, and the second was to use the QS markers in conjunction with the 
overall EPG quality to guide the rework strategy. The STR results for each sample when 
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these two rework strategies were followed and compared (if different) to see if any 
improvement in allele recovery or profile quality was achieved. 
Materials and Methods 
Sample Collection and Preparation 
A summary of sample information and chemistries used is listed in Table 5.1. All 
live-donor samples used in this study were collected from informed and consenting 
participants pursuant to approved Sam Houston State University IRB 2018-05-40949. 
Databasing Samples 
Saliva samples were collected using sterile cotton tipped applicators (Puritan, 
Guilford, Maine, USA), Bode buccal DNA collectors (Bode Cellmark Forensics, Lorton, 
Virginia, USA), and Whatman® FTA® cards with Easicollect™ devices using 
manufacturers recommended protocols; hereafter referred to as cotton swabs, Bode swabs, 
and FTA® saliva samples, respectively. For cotton and Bode swabs, samples were also 
collected with poor and dirty collection protocols to mimic poor quality samples that may 
be submitted to laboratories. The poor collection method was a single swipe from one 
cheek with cotton swabs (n=20) and Bode swabs (n=30). Dirty collections for cotton (n=7) 
and Bode swabs (n=7) were performed using the manufacturer’s protocol immediately 
after subjects had chewed gum or drank coffee.  
Whole blood (100 µL) collected from donors (n=10) in purple topped 3.0 mL K2E 
BD Vacutainer blood collection tubes (Beckton Dickinson) was deposited onto Whatman® 
FTA® cards and allowed to dry overnight. To recreate low blood volume samples, 
approximately 125 µL - 700 µL of blood (~0.25 - 1 cm in height from bottom of tube) from 
the original donor collection tube was transferred via BD Vacutainer Safety-Lok blood 
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collection set needles into unopened purple top tubes. The low blood volume tubes were 
vortexed to mix with the EDTA before transferring 100 µL onto FTA® cards.  
Mock Case Samples 
Aged biological stains were simulated by depositing 500 μL of saliva (n=5) and 
blood (n=5) on polyester and cotton blend bed sheets. The stains were air-dried overnight 
before exposure to simulated environmental insults, described in section “Simulated 
Environmental Insults on Samples”.  
DNA extracts identified as low template, inhibited, or degraded were also used in 
this study. Low template samples were sourced from touch DNA collected from handled 
rifle magazines using cotton CEP® Swabs (n=12) (FITZCO, Spring Park, Minnesota) and 
nylon FLOQSwabs™ (n=12) from Copan (Murrieta, California, USA). Low template 
and/or degraded DNA was also recovered from skeletal samples (n=20).  
Inhibited (n=20) and degraded (n=10) DNA samples were sourced from muscle 
tissue and swabs used to collect DNA from decomposing human bodies, including 
unpreserved nylon swabs and muscle tissue preserved in Tent buffer (10mM Tris, 10mM 
EDTA, 1M NaCl, 2% Tween 20; 100 mL, pH 8.0). In addition, samples (n=12) spiked with 
the inhibitors hematin (n=3, 500-1500 ng/µL), melanin (n=3, 25-60 ng/µL), humic acid 
(n=3, 100-400 µM), and 70% ethanol (n=3, 1-3 µL/PCR reaction) were made using neat 
inhibitor stocks and TaqMan® control genomic DNA (Applied Biosystems).  
Mock sexual assault samples were created by adding semen to female vaginal 
swabs. Male donors were provided a specimen container and asked to collect one emission 
of semen in the privacy of their own home. Female donors were provided cotton swabs and 
asked to collect vaginal material by swabbing for 20-30 seconds in the privacy of their own 
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home. Neat semen from two male donors was diluted with laboratory grade water to 1:25, 
1:50, 1:100, 1:250, 1:500, and 1:1000. From these dilutions, 20 µL of solution was added 
onto half of a vaginal swab. The dilution series was used with 4 different sets of female 
vaginal swabs for a total of 24 samples. Additionally, post-coital vaginal swabs (n 
=4/donor) were also collected from two female donors with collections ranging from 9 
hours to 7 days post-coitus. 
Simulated Environmental Insults on Samples 
Samples stored in hot and humid conditions were placed in an oven at 37 °C with 
open sources of water to create high levels of humidity. The cotton swabs (n=20), Bode 
swabs (n=20), and FTA® blood and saliva cards (n=10 each) were sampled from hot and 
humid conditions at various timepoints between 10 and 32 weeks to screen for degradation. 
Mock casework saliva- and blood-stained cloths were stored for 16 weeks in this same hot 
and humid environment.  
A set of Bode (n=20) and saliva FTA® saliva (n=10) swab samples were placed 
uncovered in a UVP CL-1000 ultraviolet crosslinker (AnalytikJena, Upland, California, 
USA). Bode swabs were exposed to UV radiation for 2.5, 5, 10, and 15 mins (n=5 donor 
swabs per timepoint; 1 punch per swab) and FTA® saliva samples (n=10) exposed to UV 
radiation were sampled after 1, 2.5, 5, 10, and 15 mins of exposure (n=2 donor cards per 
timepoint; 10 replicate punches per card). Cotton swabs (n=20) were degraded similarly 
under a built-in UV lamp in an Optimizer PCR Workstation (C.B.S, San Diego California, 
United States) with exposure times of 6, 12, 18, and 24 hours (n=5 donor swabs per 




TABLE 5.1 – Summary of sample information and chemistries used in this study. 
SAMPLE DETAILS NO. SAMPLES EXTRACT.  QUANT. PCR AMP. 
COTTON 
SWAB 
Room Temp 20 N/A N/A 24plex GO! 
Hot and Humid; 37°C, 13-
27 weeks 20 N/A N/A 24plex GO! 
Poor Collection 20 N/A N/A 24plex GO! 
Dirty Collection; Gum, 
coffee 7 N/A N/A 24plex GO! 
UV Exposure; 6-24 hours 30 N/A N/A 24plex GO! 
BODE 
BUCCAL 
Room Temp 20 N/A N/A 24plex GO! 
Hot and Humid; 37°C, 9-
12.5 weeks 20 N/A N/A 24plex GO! 
Poor Collection 30 N/A N/A 24plex GO! 
Dirty Collection; Gum, 
coffee 7 N/A N/A 24plex GO! 
UV Exposure; 2.5-15 mins 20 N/A N/A 24plex GO! 
FTA® 
SALIVA 
Room Temp 150 N/A N/A 24plex GO! 
Hot and Humid; 37°C, 13-
27 weeks 100 N/A N/A 24plex GO! 
UV Exposure; 1-15 mins 100 N/A N/A 24plex GO! 
FTA® 
BLOOD 
Room Temp 150 N/A N/A 24plex GO! 
Hot and Humid; 37°C, 13-
27 weeks 100 N/A N/A 24plex GO! 
Low Blood Volume 
(LBV); 0.25-1 cm 100 N/A N/A 24plex GO! 
LBV Direct Amp; 0.25 cm 
no lysis buffer 20 N/A N/A 24plex GO! 
STAINED 
CLOTH 
Blood; 37°C, 16 weeks 5 EZ1 Investigator Investigator Pro RGQ 24plex QS 
Saliva; 37°C, 16 weeks 5 EZ1 Investigator Investigator Pro RGQ 24plex QS 
INHIBITED 
Identified 20 Varied Investigator Pro RGQ 24plex QS 
Spiked 12 N/A Investigator Pro RGQ 24plex QS 
TOUCH 
Nylon Swab 12 QIAamp Investigator 
Investigator 
Pro RGQ 24plex QS 
FloQ Swab 12 QIAamp Investigator 
Investigator 
Pro RGQ 24plex QS 
SKELETAL   20 Total Demin. Investigator Pro RGQ 24plex QS 




Cotton Swab; 1:25- 1:1000 24 EZ1 Investigator Investigator Pro RGQ 24plex QS 
POST 
COITAL Cotton Swab; 9 hrs-7 days 8 EZ1 Investigator 
Investigator 
Pro RGQ 24plex QS 
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DNA Extraction  
Mock Case Samples 
From the biologically stained cloths, 0.5 cm2 cuttings were added to 490 µL of ATE 
buffer and 10 µL proteinase K (QIAGEN) and incubated at 56 °C for 15 mins. The resulting 
lysate was purified using the Large Volume Protocol on an EZ1 Advanced XL automated 
extraction platform (QIAGEN) with a 40 µL elution volume.  
Mock sexual assault samples and post coital samples underwent manual differential 
separations with the sperm and epithelial fractions extracted separately using automated 
protocols on the EZ1 XL. Briefly, 480 µL of G2 solution and 20 µL of proteinase K 
(QIAGEN) were added to a half-swab cutting. The cuttings were then lysed at 56 °C and 
900 RPM for 1.5 hours on a thermal shaker. After removing the cutting from the lysis tube, 
the lysate was centrifuged at 15,000 RPM to pellet the sperm fraction. The epithelial 
fraction (~460 µL) was then aspirated and added to a 2 mL sample tube containing 400 µL 
of MTL buffer (QIAGEN) before performing DNA purification on an EZ1 XL using the 
Large Volume Protocol with an elution volume of 40 µL in TE. The sperm fraction was 
processed according to the Pretreatment for Epithelial Cells Mixed with Sperm Cells 
protocol of the EZ1 DNA Investigator® Handbook (29) and purified with the EZ1XL Trace 
Sample Protocol with resulting DNA eluted in 40 µL of TE buffer.  
DNA Quantification and Amplification 
A QIAGEN QIAgility® liquid handling platform was used to prepare all samples 
for quantification and amplification. All mock case samples were quantified using the 
Investigator® Quantiplex® Pro RGQ kit on a QIAGEN Rotor-Gene® Q platform with Q-
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rex software as per manufacturer’s guidelines. Results were analyzed with the QIAGEN 
Data Handling Tool and data were accepted with an R2 value > 0.99. 
Databasing samples were amplified with no quantification using the QIAGEN 
Investigator® 24plex GO! chemistry. An overview of workflows for cotton and Bode 
swabs, as well as saliva and blood FTA® cards, can be seen in Appendix Figures D1 and 
D2, respectively. Both cotton and Bode buccal swabs were amplified according to the 
manufacturer’s guidelines in the Investigator® 24plex GO! Handbook with the cycling 
number modified to total 26 PCR cycles. Full swab heads were lysed and consumed for 
each cotton swab and a single 1.2 mm punch was taken from each Bode swab.  
For both saliva and blood FTA® cards, a single 1.2 mm punch was deposited in a 
0.2 mL 96- well plate with 10 punch replicates per sample. Using the QIAgility, 20 µL of 
STR GO! Lysis Buffer was directly added to the punches. This was then centrifuged and 
incubated at 95 °C for 5 mins. The QIAgility was then used to add 2 µL of the appropriate 
crude lysate to 20 µL of 24plex GO! Master Mix for FTA® samples. Additionally, a subset 
of 10 low blood volume FTA® samples were directly amplified in duplicate without use of 
the GO! Lysis buffer. All FTA® blood and saliva samples were amplified with a total 
number of 27 PCR cycles.  
All mock case work samples targeted a final input DNA per reaction of 0.8 ng. 
Samples were amplified with the QIAGEN Investigator® 24plex QS kit according to 
manufacturer’s protocol on either a ProFlex (Thermo Fisher, Waltham, Massachusetts, 





Capillary Electrophoresis and Data Analysis 
Amplified fragments were separated and detected on an Applied Biosystems 3500 
Genetic Analyzer (Thermo Fisher Scientific) according to manufacturers recommended 
guidelines. Data analysis was completed using GeneMapper IDX v1.4 (Thermo Fisher 
Scientific) with tertiary analysis being accomplished with in house excel workbooks. 
Stochastic and analytical thresholds were set at 200 RFU and 100 RFU, respectively.  
Quality Metrics Concordance Study 
Following STR data analysis, any discrepancies between information provided by 
the qPCR quality control flags, QS markers, and the overall STR profile quality were 
identified for all mock case samples. The categories of incorrect flags or information 
mismatches relative to the qPCR quality controls were as follows: unidentified 
degradation, inflated DI, unidentified inhibition, false inhibition flag, unidentified mixture, 
false mixture flag, and more than one incorrect. “Unidentified” categories were defined as 
having an issue observed in the STR profile, either based on the QS markers or visual 
inspection, but were not flagged during qPCR. Conversely, when an issue was flagged 
during qPCR, but not observed in the STR profile it was labeled as a “false” flag. To note, 
any sample that did not have a DNA concentration at one or both of the male targets was 
automatically flagged as having “possible male degradation” by the Data Handling Tool. 
This meant that all female samples had this quality flag, but this was not considered as an 
occurrence of an “incorrect flag” for the purpose of this study. 
Sample Reworks 
A sub-set of single-source database and mock casework samples with <90% 
reportable alleles (n=79) after amplification were further evaluated to test the applicability 
137 
 
and benefits (if any) of the information provided by the QS markers. This was achieved by 
comparing the first-pass results to those of secondary amplifications performed based on 
rework strategies that were determined either with or without the quality sensor 
information. First, electropherograms with the QS markers redacted were provided to 
external forensic DNA analysts to remove the potential for bias. Basic information 
necessary for the determination of the appropriate rework strategy, such as sample group 
(databasing vs casework) and type (blood vs buccal vs DNA extract), substrate 
(cotton/Bode swab vs FTA® card), and quantification data (if applicable), was also 
provided. Using their experience, the analysts were asked to identify what they thought 
was causing any problems observed in the STR profile, and using their judgement and 
laboratory’s SOPs, what their approach to additional analysis (if any) would be based on 
the overall quality of the STR profile. This rework strategy was then compared to how 
other analysts chose to reanalyze the same samples when electropherograms were assessed 
with the QS markers included.  
Samples were categorized as being either inhibited, low template and/or degraded, 
no DNA, or a failed amplification. When assessing EPGs with the QS markers included, 
inhibition was suspected and/or confirmed when one or more of the following occurred: 
possible inhibition was flagged during qPCR (IPC shift of 1+ cycles); the S/Q ratio fell 
between 20-70% with some visual indicators of inhibition throughout the EPG; the S/Q 
ratio fell below 20%; or one or both QS markers failed to amplify. Low template/degraded 
samples were classified when consistently low peak heights (average peak heights of 
approximately <750 RFUs) and/or a ski slope effect throughout the EPG were observed 
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with balanced QS markers. Finally, failed amplifications due to no DNA template had no 
alleles present throughout the EPG except for balanced QS markers.  
After determining an approach for each sample, the two rework strategies were 
compared and performed on all samples (if different). Databasing samples labeled as low 
template/degraded were reworked with an increased template by either adding an 
additional microliter of lysate (total of 3 µL) if available, or two 1.2 mm punches in the 
amplification reaction. However, for casework samples requiring additional template in the 
PCR, if the maximum input had already been used, no rework was performed. Inhibited 
samples were either diluted 1:3, or a punch was washed with GO! lysis buffer before 
reamplifying. For a failed amplification reaction, samples were processed in the same 
manner as before either from the original lysate/extract or a new punch. No PCR cycling 
or CE parameters were changed for any rework strategy. 
Results and Discussion 
First-Pass Results 
Databasing Samples 
A summary of first-pass results for all databasing samples is shown in Figure 5.1. 
The control group consisted of swabs or FTA® cards collected and then stored at room 
temperature. All other samples were intentionally exposed to challenging conditions to 
create a range of compromised samples in order to test the benefits of the quality sensors. 
All room temperature controls for cotton and Bode buccal swabs generated full STR 
profiles on the first amplification (Fig. 5.1). All but a single replicate from one FTA® card 
resulted in full STR profiles for punches taken from the center of FTA® blood cards stored 
at room temperature (Fig. 5.1). However, direct amplification from saliva on FTA® saliva 
139 
 
cards resulted in a lower first-pass (83.3% of samples) (Fig. 5.1) with an average of 93.8% 
reportable alleles. The observance of reduced or variable STR success for saliva samples 
stored on FTA cards compared to that of blood has been previously reported as likely due 
to inhibitors within the saliva (30), low amounts of collected cells (31), or cells clumping 
in different areas of the substrate (32). A majority of the sample replicates that failed to 
generate full STR profiles were attributed to two of the ten donors, which could be due to 
a natural variation in shedding propensity between donors and/or the collection process 
itself as swabs were self-collected by the donors. QS markers did not indicate inhibition 
(all S/Q ratios >20%) for any room temperature sample (Appendix Fig. D3). Overall, with 
the exception of some FTA® saliva samples, STR profiles for room temperature controls 
were well balanced (average PHR >80%), with average peak heights greater than 1000 
RFUs.  
First-pass rates for swabs and FTA® cards stored in a hot and humid environment 
ranged from 65-85% of samples generating complete profiles (Fig. 5.1). Sub-sampling 
from two of the FTA® saliva donor cards after 13 weeks in hot and humid conditions 
yielded notably different results from the others. While the rest of the donor cards averaged 
over 95% reportable alleles, one donor card had an average of 63.4% reportable alleles and 
the other had no reportable alleles for any of the replicate punches. The Q/S ratios did not 
indicate PCR inhibition; therefore, it was likely that little or no DNA was present on the 
cards. It was not possible to re-collect those samples from the donors, and therefore, these 
data from those donor cards were excluded from the remainder of the study. However, this 
observation was a perfect example of when the QS markers were able to inform the analyst 
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that no DNA was present (as opposed to severe inhibition) and therefore avoided 
unnecessary reamplification of those samples.   
For the remaining FTA® cards, overall profile quality declined with prolonged 
exposure to heat and humidity, but saliva samples consistently generated complete (or near 
complete) and balanced profiles on average (>90% alleles; >70% average peak height 
ratios), regardless of the collection substrate, for up to 32 weeks (Appendix Fig. D4-5). 
However, blood preserved on FTA® cards showed to be the most susceptible to hot and 
humid conditions as the average number of reported alleles dropped from nearly 100% 
after 10-14 weeks of storage, to less than 75% after 24-27 weeks of storage (Appendix Fig. 
D4) and profiles became less balanced with an average PHR of 55% (Appendix Fig. D5).  
For samples subjected to UV damage (cotton, Bode, and FTA® saliva/buccal 
swabs), first-pass success rates ranged from 0-50% (Fig. 5.1), with cotton swabs 
consistently yielding more reportable alleles on average compared to Bode and FTA® 
samples. Cotton swabs also required much longer exposure to UV light than the Bode 
swabs and FTA® cards before allele dropout was observed (several hours vs 2.5 mins). 
These results may be explained by fact that the surface area and composition of cotton 
swabs likely allow for more protection against UV damage compared to Bode and FTA® 
cards, where DNA is trapped on a flat and relatively exposed surface. As expected, the 
overall quality of STR profiles for each sample type decreased with increasing UV 
exposure (Appendix Fig. D6-7). For Bode swabs and FTA® samples, no full profiles were 
observed after 2.5 mins of exposure to UV light (Appendix Fig. D6). However, full profiles 







FIG. 5.1 - First-pass success rates for environmentally challenged databasing samples: buccal swabs (left) and blood on FTA® cards 
(right). First-pass success rate was defined as the percentage of samples that generated complete STR profiles using the Investigator® 
24plex GO! Kit (QIAGEN). *N/A indicates that the insult category was not tested for that substrate. (Cotton - n = 20, n = 20, n = 20, n 





While these conditions may not accurately reflect real-life UV exposure, they 
demonstrate the differences in susceptibility to UV damage between the substrate types 
and the performance of the QS markers. The QS markers did not indicate the possibility of 
inhibition for any hot and humid samples, but did accurately confirm that allele dropout 
was likely due to DNA degradation in all but one sample. The single UV degraded swab 
that flagged possible inhibition had an S/Q ratio of 19%, which is just below the 20% 
threshold, but still resulted in a complete reportable profile. When the EPG was 
interrogated further, there appeared to be potential chromatography issues, so the sample 
was simply reinjected instead of fully reworked. As a result, the overall profile quality was 
resolved and the S/Q ratio was restored to 86% (Appendix Fig. D8). This case demonstrates 
that rather than using the 20% S/Q ratio as a strict threshold for rework determination, the 
QS information can support the analysts’ best judgement and experience for the most 
appropriate strategy moving forward to avoid any unnecessary reamplification. 
The first pass rate for FTA® blood cards spotted with blood from EDTA tubes 
containing 0.25 - 1 cm of blood was 98% when processed with the GO! Lysis Buffer prior 
to amplification. However, when the 0.25 cm blood collection cards were directly 
amplified without a pre-lysis step, no full STR profiles were obtained, with the percentage 
of reportable alleles ranging from 0 - 78% (Appendix Table D1). According to the 
Investigator® 24plex GO! Handbook (20), an S/Q ratio of <20% is indicative of inhibition. 
Although not explicitly stated, a high degree of PCR inhibition could also be assumed with 
the complete dropout of the larger quality sensor (‘S’), and inhibition must also be 
considered when dropout of both quality sensors occur (severe inhibition that stalls PCR 
completely). The direct amplification sample group was the only set of databasing samples 
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that had one or both quality sensors drop out, which occurred for both duplicate punches 
(Appendix Table D1).  
We did observe one instance of an S/Q ratio <20% for a lysed 0.25 cm low blood 
volume sample, as well as a previously mentioned UV-exposed cotton swab (with 19% 
Q/S ratio). However, for both of these samples 100% alleles were reported with high 
average peak heights (>3300 RFUs), and balanced heterozygous peak height ratios 
(>85%), which demonstrates how the information provided by the quality sensors is not an 
absolute determination and should be considered in conjunction with the STR profile as a 
whole during the data interpretation process. 
When swabs were used to mimic sub-optimal collection techniques (a single swipe 
of one cheek or when the subject had chewed gum or drank coffee immediately before 
collection), full profiles were generated from all but four cotton and two Bode buccal swabs 
(Fig. 5.1). The poor collection swabs that did not yield full profiles had notably less 
amplified DNA (average peak heights <250 RFUs), but nevertheless resulted in over 80% 
reportable alleles. These results may be expected due to the small number of buccal cells 
(and saliva) that were likely collected. The sample that yielded the worst result was a cotton 
buccal swab collected after an individual chewed cinnamon gum. Only five alleles (11.4%) 
were reportable, but the S/Q ratio was 70%, confirming that a low amount of DNA was 
likely collected or released during lysis, and that PCR inhibition was not likely a 
contributing factor.  
Mock Case Samples – Single Source 
A range of low template and/or degraded samples were represented by a set of 
previously extracted skeletal (n=20) and touch (n=24) items that resulted in first-pass rates 
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of 60% and 20.8% samples generating full profiles, respectively (Fig. 5.2). For the skeletal 
samples, one DNA extract had a concentration of 2.97 ng/µL while the rest ranged from 
0.013 – 0.457 ng/µL. All of the touch samples had DNA concentrations of less than 0.031 
ng/µL. In addition to having higher DNA concentrations, DNA from the skeletal samples 
was more degraded than the touch DNA, with degradation indices (DIs) ranging from 2.7 
– 168.2 versus 1.0 - 7.8. However, it should be noted that the larger DIs (DI > 50) for the 
skeletal samples may be artificially inflated due to also being in very low amounts of DNA 
(0.01-0.03 ng/µL) and stochastic effects during amplification. Additionally, four low 
template samples had a DNA concentration of either 0.0 or ‘unknown’ for the Human 
Degradation target (long autosomal target) and therefore a DI could not be calculated. No 
inhibition was detected during DNA quantification, as determined by the Investigator® 
Quantiplex® Pro RGQ inhibition index (all IPC ΔCT shifts were <1 cycle). As there was 
more DNA template available for amplification in the skeletal extracts, it was not 
unexpected that more alleles on average were reported for skeletal samples (90%) 
compared to touch samples (60%). Nevertheless, all samples generated at least a partial 
profile (>10% alleles) and full STR profiles were obtained with as little as 0.05 ng DNA. 
Finally, with the exception of a single skeletal DNA extract, no PCR inhibition was 
indicated by the STR Quality Sensors, which was concordant with the information 
provided by the IPCs during DNA quantification. In all other low template samples, the 
QS markers also confirmed that the observed allelic dropout was due to low amounts of 
DNA and/or degradation rather than inhibition. 
Degraded samples were extracted from decomposed human muscle tissue (n=10) 
and blood or saliva stains on cloth (n=10) that were artificially degraded in a hot (37 °C) 
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and humid oven for 16 weeks. DNA concentrations averaged 14.2 ng/µL and 0.8 ng/µL 
for decomposed tissues and degraded stains, respectively. With the high amount of DNA 
available, the target amount of DNA for PCR (0.8 ng) amplified for all but one sample, 
which was the only sample to generate a profile with less than 97% reportable alleles. In 
fact, this one sample failed to amplify any alleles despite having a DNA input of 0.3 ng 
and no indicator of inhibition during DNA quantification or when the QS peaks were 
examined (Q/S ratio of 130%). Therefore, this sample was selected to be further evaluated 
during the Sample Reworks phase of the study. Although full STR profiles were generated 
for most samples and the DIs were not high enough to flag degradation (all DIs were < 10) 
during DNA quantification, the characteristic “ski-slope” effect was still observed 
throughout the EPGs. No PCR inhibition was indicated during DNA quantification or STR 
amplification as determined by the IPCs or QS markers respectively. 
A variety of common PCR inhibitors (melanin, hematin, humic acid, and ethanol) 
in a range of concentrations, and DNA extracts that had been previously identified as 
inhibited were also examined. These samples produced two of the lowest first-pass rates 
for all of the mock casework samples with only 5% of soft tissue DNA extracts (n=20) and 
50% of spiked DNA samples (n=12) resulting in full STR profiles (Fig. 5.2). During DNA 
quantification, inhibition was flagged for all of the tissue extracts and the samples with 
high and moderate concentrations of hematin and humic acid. Due to the high levels of 
inhibition, the longer (“degradation”) human and male targets failed to amplify (with the 
exception of the moderate concentration hematin sample), which resulted in DIs not being 
able to be calculated. Although these samples would normally be diluted and then re-
quantified to determine a more accurate DNA concentration, for this study we wanted to 
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assess the full effects inhibition would have on the QS markers in the STR kit. Therefore, 
samples that flagged as inhibited during qPCR were not pre-diluted unless it was required 
to bring the DNA concentration to the 0.8 ng target for STR amplification.  
The Investigator® 24plex QS kit was highly tolerant to the low concentrations of 
ethanol, hematin, and humic acid as well as all three concentrations of melanin used in this 
study (Appendix Fig. D9). However, despite a full profile being generated for the high 
melanin concentration, the S marker dropped to 12.7% of the Q marker (falling below the 
20% threshold for detecting PCR inhibition), and visible signs of inhibition (inter- and 
intra-locus allele imbalance) were apparent. Partial inhibition was observed for the 
moderate and high concentrations of humic acid and moderate concentration of hematin, 
with samples resulting in 10-99% reportable alleles. The moderate and high concentrations 
of ethanol, and high concentration of hematin, resulted in near (<10% alleles) or complete 
(0% alleles) inhibition (Appendix Fig. D9). Finally, only two of the tissue extracts resulted 
in any alleles being amplified (>97% alleles) as these samples were the only extracts that 
required dilution prior to amplification; the rest were completely inhibited and failed to 
amplify any alleles. As anticipated, a wide range of QS values and STR profile 
completeness were observed with these samples containing various levels of common PCR 
inhibitors (Fig. 5.3). When full STR profiles were obtained, both of the QS markers were 
present, as expected. However, in samples with sufficient DNA template in the PCR, 
dropout of the S marker mirrored the amplification failure of the larger loci, while the Q 
marker did not drop out until severe inhibition was observed across all loci (<10% alleles). 
This behavior of the QS markers in the presence of increasing concentrations of inhibitors 






FIG. 5.2 - First-pass success rates for single-source mock casework samples based on insult category and sample type. First-pass 
success rate was defined as the percentage of samples that generated complete STR profiles using the Investigator® 24plex QS Kit 







FIG. 5.3 - Distribution of QS values for inhibited mock casework samples (n=32) based on STR completeness. 
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Mock Case Samples – Mixtures 
As expected, the amount of male DNA recovered in the sperm fractions decreased 
as the serial dilution of neat semen (Appendix Fig. D10) and the time post-coitus 
(Appendix Fig. D11) increased. The female epithelial fractions were not STR-typed for 
this study. Despite the multiple wash steps for the sperm fractions, there was still a high 
proportion of female carry-over (>5:1 ratio) for nearly half of the mixture samples, with a 
consistently low recovery of male DNA (<0.06 ng/µL on average). This negatively affected 
the overall recovery of male alleles as some of the extracts then required dilution prior to 
amplification, further reducing the amount of male DNA available for amplification. 
Although not tested in this study, the use of Y-STRs may have led to more probative 
information in these cases as a dilution would not be necessary, allowing for maximal male 
DNA for amplification. Previous studies have shown the benefits of Y-STR typing for low-
level male:female mixtures, with successful detections of male alleles from samples with 
mixture ratios as high as 1:4000 (35-38). Additionally, Y-STRs might also provide an 
opportunity to better observe a correlation between any male degradation flagged during 
quantification and any degradation present in the profile (26, 27) for mixed samples such 
as these.  
The number of shared alleles between the male and female donors in the dilution 
series group ranged from 10-16 alleles and sperm fraction human to male ratios ranged 
from 0.76:1 to 45.9:1. Obligate male alleles were able to be detected in STR profiles with 
as little as 15 pg of male input DNA and a human to male ratio of 24:1 for a semen dilution 
sample of 1:1000. However, across the dilution series for sperm fractions with a human to 
male ratio greater than 9:1, no more than two obligate male alleles were detected. Of the 
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24 sperm fractions, four full male profiles were obtained for 1:25 and 1:50 semen dilutions, 
no male alleles were detected in the STR profiles for two of the 1:1000 semen dilutions, 
and the rest had partial male profiles ranging from 2% to 91% of obligate male alleles 
detected (Fig. 5.4). 
For the authentic post-coital samples, male DNA was detected as late as 5 days 
post-coitus (0.003 ng/µL); however, more than a single male allele was only amplified only 
until day 3 post-coitus, and a full male profile only being obtained after 9 hours post-coitus 
(Fig. 5.5). Major and minor contributor alleles were distinguishable for three of the sperm 
fractions at 9 hrs, 12 hrs, and 3 days post-coitus. This is consistent with other studies that 
show that 2-3 days post-coitus is typically the limit for obtaining male autosomal STR 
alleles (7, 9, 39). However, the use of Y-STRs provide more complete male profiles (7-9) 






FIG. 5.4 - Male profile completeness observed in the sperm fractions (n=1 each) of mock sexual assault samples based on the dilution 
of semen, and amount of male DNA amplified. Semen from two male donors were used for the dilution series. Bars with a shaded 







FIG. 5.5 - Male profile completeness observed in the sperm fractions of authentic post-coital samples (n=1 each) after (9 hrs, 12 hrs, 
3, 5, and 7 days), and amount of male DNA amplified. Bars with a shaded background denote samples that were flagged as mixtures 




Concordance between quality flags during qPCR in the RGQ kit, the STR quality 
sensor information, and the overall profile quality was evaluated. Of the 133 mock 
casework samples in this study (single-source and mixtures), 103 showed full concordance 
between the two internal quality control metrics and the overall STR profile (Fig. 5.6). As 
the Investigator® Quantiplex® Pro RGQ kit is relatively new to the market, limited research 
has been published regarding the predictability of the qPCR data for STR typing. However, 
the few studies that have published these kinds of data report a high concordance between 
the two sets of metrics (25, 26, 40). In this study, the most common mismatch observed 
was when degradation in the STR profile was not detected during quantitation (6% of 
samples), followed by false inhibition flags (4.5% of samples flagged as inhibited during 
qPCR but not seen in STR profiles) and unidentified mixtures (mixture seen in profile but 
not detected during qPCR) (Fig. 5.6). Other, less frequent discrepancies, included 
inhibition not detected during qPCR (2.3%), two mismatched flags (e.g. false inhibition 
plus unidentified mixture), and a single instance of a false mixture being flagged for a 
known single-source male sample with no extra alleles in the EPG.  
The samples with unidentified degradation (not flagged during quantification) 
showed a visible ski-slope effect throughout the profile, and although no allele dropout had 
occurred, the allele peak heights at the larger loci were reduced to less than half of those at 
the smaller loci. The default settings in the Data Handling Tool flag degradation at a DI of 
>10 during quantification, and even though signs of DNA degradation were consistently 
visible in STR profiles at DI values of 2.5 or greater, the default threshold of 10 was 
































FIG. 5.6 - Percentage of mock casework samples (n=133) that showed concordance between quality flags in the Investigator® 
Quantiplex® Pro RGQ kit during DNA quantification and the Quality Sensors and profile quality in the Investigator® 24plex QS kit 
(left). Disconcordance (right) was categorized as follows: inflated degradation index (DI), unidentified degradation, unidentified 






FIG. 5.7 - The relationship between the level of degradation (DI value) and the resultant percentage of reportable alleles from skeletal 
(n=20) and other degraded tissue (n=20) samples. The dashed line represents the default degradation analysis threshold (DI of 10), 
when degradation is automatically flagged by the Data Analysis tool during DNA quantification. Three skeletal samples with DIs over 




All but one of the false inhibition flags were from samples that had an IPC shift just 
over the 1-cycle threshold (e.g. -1.069), but the EPGs showed balanced QS markers with 
no visible effects of inhibition in the STR profile. This threshold of a 1-cycle shift is the 
default setting in the Data Handling Tool, but can be modified as needed based on internal 
laboratory validation. Additionally, the Investigator® 24plex QS kit has been shown to be 
highly tolerant to common inhibitors than other commercial STR kits (33, 41), and 
although the Investigator® Quantiplex® Pro RGQ kit was designed to reflect the same level 
of tolerance, the two kits may not always behave exactly the same due to the different 
sample input amounts. The only other sample that was flagged as inhibited during qPCR, 
but did not exhibit signs of inhibition upon STR typing, had a high DNA concentration and 
was therefore diluted prior to PCR, which therefore also diluted out the inhibitor. Lastly, 
the unidentified mixture samples had flagged mixture indices ranging from 0.94:1 to 1.9:1, 
which again fell just under the default threshold of 2:1. This was an interesting 
phenomenon as EPGs with nearly full male and female profiles present were generated 
from samples that had similar DNA concentrations for the human and male targets as 
determined by the Quantiplex® Pro RGQ kit (Example – Appendix Fig. D12), when the 
human target should theoretically have double the male target DNA concentration for a 1:1 
female/male mixture, as previously demonstrated with this kit (40). With observance of 
some discordance between human and male targets for single-source samples, it is 
hypothesized that either the human DNA concentration was under-estimated and/or the 






In addition to the Investigator® 24plex QS and GO! kits, several commercial STR 
kits that include internal PCR controls, such as Thermo Fisher Scientific’s NGM Detect® 
(42) and VeriFiler® Plus (43) kits and QIAGEN’s Investigator® ESSplex SE QS (44) and 
Investigator® 26plex QS (45) kits, have been designed with the goal of assisting analysts 
in the interpretation of challenging profiles. The most commonly reported benefit of these 
quality control systems is being able to differentiate between inhibited and degraded 
samples (21-23, 42-48), and using that information to determine the workflow for further 
analyses.  
Although a few published studies have reported that the QS markers in the 
Investigator® 24plex QS and GO! kits have the ability to better guide rework strategies, 
most of these studies were performed by the manufacturer and included minimal rework 
data (21-23). At the time of this study, our work was the most extensive comparison of 
reworks using the QS markers, for both mock casework and database-type samples. A 
subset of samples (n=79) with incomplete STR results (<90% alleles reported) during the 
first-pass analyses were selected for potential reworking. Samples were reworked 
according to the strategy determined by DNA analysts when they reviewed 1) the STR 
profile alone (no QS markers), and 2) the STR profile with the QS markers included.  
After the rework strategies had been performed, there was an increase in reportable 
alleles for 63 samples, regardless of the approach used to define the rework strategy. The 
16 samples that showed no improvement after reworking either had very little or no DNA 
and/or were highly degraded, or in the case of one sample, was both low template and 
severely inhibited. When the two rework strategies were the same (n=54), the average 
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number of reportable alleles increased from 13% to 48.7% (Fig. 5.8), overall profile quality 
improved (Fig. 5.8) and full profiles were able to be generated for 14 additional samples.  
For almost one third of the samples (n=25) the analysts determined a rework 
strategy based on the STR profile alone that was different from the rework approach to be 
taken when the profile was examined with the QS markers included. An average increase 
in alleles (from 29.3% to 41.9% profile completeness) and overall profile quality was 
observed (Fig. 5.9), as well as generation of 8 full profiles with the non-QS information 
approach. However, even greater improvement was observed when samples were reworked 
based on the QS markers. Allelic balance improved, STR completeness increased to 76.2% 
reportable alleles (Fig. 5.9), and 17/25 samples produced full profiles when reworked based 









FIG. 5.8 - Comparison of STR profile quality metrics between the original amplification and the secondary rework amplification for 
samples (n=54) that were reworked using the same strategy regardless of whether the QS marker information was taken into 
consideration. Quality metrics included average: reportable alleles (left), peak heights and peak height ratios (right). Error bars 








FIG. 5.9 - Comparison of STR profile quality metrics between the original amplification and the secondary rework amplification for 
samples (n=25) that had different rework strategies with and without the QS marker information being considered. Quality metrics 










FIG. 5.10 - Comparison of amplification success between the original and secondary amplifications (reworks determined with and 
without the QS marker information) for each sample that was reworked with different approaches (n=25). Samples were classified 
three into general insult categories; degraded (n = 10), inhibited, (n=10), and miscellaneous (n=5). 
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The most notable improvement was observed for severely inhibited samples that 
originally failed amplification (Fig. 5.10-11). Without the QS markers, the analyst assumed 
no DNA was present in that particular sample and therefore the strategy was to fully 
reprocess the sample (e.g. process a new FTA® punch). As inhibition was the reason for 
failure, the same result as before, or worse, was achieved. However, for these samples, one 
or both of the QS markers dropped out which is an immediate indicator of severe inhibition 
and therefore, the appropriate strategy would be to perform a dilution or water wash prior 
to re-amplification. This strategy resulted in full profiles for all 10 inhibited samples (Fig. 
5.10).  
 
FIG. 5.11 - Comparison of the average amplification success between the original and 
secondary amplifications (reworks determined with and without the QS marker 
information) for all reworked samples (n=79). Samples were classified three into general 
insult categories; degraded (n=34), inhibited (n=40), and miscellaneous (n=5). Error bars 
denote the standard error of the mean (SEM). 
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There were two instances where the internal analysts’ rework strategy 
determination was uncertain based on their interpretation of the overall profile quality and 
the QS marker information. Obvious signs of DNA degradation were observed throughout 
both profiles, but there were also some indications of possible inhibition coupled with the 
S marker height reduced to 55-70% of the Q marker. Therefore, a dilution was performed 
to see if inhibition was having an adverse effect during PCR. The diluted samples produced 
less alleles (11-23% less). However, when the samples were reamplified with more 
template, more alleles (4-21% improvement from original) were recovered. While the 
manufacturer’s recommendation of a 20% S/Q ratio can be adjusted and interpreted as 
necessary based on laboratories’ internal validations, throughout this study it was a reliable 
indicator for determining the presence of inhibition that would negatively affect 
downstream STR typing results to the point when allelic dropout occurred. Finally, there 
were four samples that showed no improvement with either strategy (Fig. 5.10). These were 
severely degraded and/or had very low amounts of DNA.  
Overall, these results suggest that although experienced analysts may be proficient 
at identifying the reason for sub-optimal results solely based on the STR profile and apply 
the appropriate rework strategy for a wide variety of samples, the information provided by 
the QS markers can provide additional support for interpreting more unclear STR data. The 
QS markers were able to more frequently and accurately resolve ambiguous low-quality or 
failed STR profiles (particularly severely inhibited samples) (Fig. 5.12), leading to the most 







FIG. 5.12 - Identified reasons for suboptimal STR results for all samples with <90% alleles which were selected for reworking (n=79).  
Classifications were determined based on the overall EPG quality: without (left) and with (right) the QS marker information. Samples 
were designated as being: inhibited, degraded, low template, a failed amplification/no template, low template and inhibited, or degraded 




The Investigator® Quantiplex® Pro RGQ and Investigator® 24plex QS and GO! kits 
performed well for a wide variety of challenging database and casework-type samples 
showing consistency between the sample quality metrics in both quality systems and as a 
HID workflow as a whole. Both casework chemistries were also sensitive and robust 
enough for a wide range of female:male mixtures. Following a manual differential 
separation and automated DNA extraction, male DNA was able to successfully be detected 
and amplified in sperm fractions from vaginal swabs collected as late as 5 days post-coitus 
(0.003 ng/µL; single obligate male allele at DYS391) and with spiked semen dilutions as 
low as 1:1000 (0.001-0.003 ng/µL; 1-2 obligate male alleles). As expected, the control 
samples collected and stored room temperature generated high first-pass rates, while a 
much higher percentage of samples with partial profiles were obtained from extremely 
degraded, low template, and/or inhibited samples.  
The QS markers correctly confirmed the quality of samples and STR profiles for 
99.9% of databasing samples and 98.4% of mock casework samples. Regardless of the 
approach used to determine the rework strategy, a notable improvement in allele recovery 
was achieved for 80% of samples that were reworked with an average increase of 21 
additional alleles, and an additional 32 samples generated full profiles after reamplification. 
However, the greatest improvement in STR quality and completeness was attained for 
samples when the EPG was analyzed in conjunction with the QS marker information. In 
particular, the quality marker systems were most beneficial in confirming PCR inhibition, 
which could guide the analyst to use the most effective rework strategy, and thereby avoid 
any unnecessary sample processing. 
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In summary, the quality sensors in the Investigator® 24plex QS and GO! kits 
allowed for a reliable and simplified interpretation of ambiguous and failed STR profiles 
to confirm sample quality and inform the best strategy for reworking samples. 
Additionally, quality flags in the Investigator® Pro RGQ kit accurately predicted sample 
quality in a majority (77.4%) of the mock casework samples tested in this study and were 
consistent with the QS markers in the Investigator® 24plex QS and GO! kits and the STR 
profiles as a whole. The combination of these quality control systems within a DNA 
workflow can help analysts determine the best way to efficiently triage and process 
challenging samples to reduce the amount of reworks required, ultimately saving both time 
and resources. However, as this study has demonstrated, these systems are not 100% 
predictive and have been shown to occasionally provide conflicting information. 
Therefore, the data provided by the sample quality flags and quality sensors should be used 
to complement an analyst’s experience. In addition, all data analyses involving the quality 
sensors and how they could be used to triage samples or determine rework strategies should 
be guided by comprehensive internal validation studies.   
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The overall results of this research have shown that the use of alternative DNA 
extraction and STR profiling methods can provide solutions for commonly encountered 
forensic issues, such as DNA degradation, low amounts of DNA, and PCR inhibition, to 
improve overall genotyping success for a wide range of challenging samples. The results 
of Phase 1 show that powdering of bone tissue may be avoided without significantly 
reducing DNA yield and STR success. Although the complete demineralization method 
seemed to extract the most DNA from bone samples and generate the most complete STR 
profiles, no statistical difference was observed compared to the other two manual methods 
tested in this study (PrepFiler® BTA, and TBone kit coupled with the PrepFiler® BTA kit). 
Data suggest that manual DNA extraction from whole bone chips (using the TBone kit) is 
comparable to traditional complete demineralization and commercial kit-based methods 
that require powdering of the bone tissue prior to extraction. Avoiding the bone powdering 
steps during sample preparation can reduce the potential for contamination and the overall 
sample processing time. Additionally, it can also eliminate the possibility of sample loss 
during crushing (e.g. tube breaking, metal shavings from magnetic bar), provides the option 
for re-extraction from the same bone fragment rather than having to cut more bone, and 
most importantly, this method may also allow more forensic laboratories to perform 
extractions from skeletonized remains that otherwise would not have been able to.  
Although automation reduces processing time and the potential for human error, 
there are also some disadvantages. Compared to performing a manual DNA extraction, a 
significant decrease in DNA yield was observed when bone samples were extracted using 
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an automated platform. Sample loss can be detrimental, especially in forensic or ancient 
cases that have a very limited amount of bone available; therefore, most laboratories prefer 
to perform DNA extractions manually. For skeletonized remains, automated techniques 
could be used for screening samples and determining the most appropriate DNA workflow. 
Samples that have adequate amounts of starting material and/or are less degraded could be 
genotyped using standard laboratory protocols. If the DNA yield is insufficient for routine 
STR typing, then a more vigorous manual DNA extraction method, such as total 
demineralization, may be performed. As a last resort, mitochondrial DNA typing has 
traditionally been relied upon for identifying samples that have low amounts of DNA. 
However, with the emerging technology of next generation sequencing, highly degraded 
and low template samples have been successfully genotyped with STRs and/or the 
combination of other alternate markers, such as SNPs and INDELs.   
For Phase 2, a powder-free workflow for skeletonized remains was optimized and 
applied to a variety of environmentally challenged skeletal elements. A single 50 mg chip 
yielded comparable results in DNA concentration and STR success to 50 mg of bone 
powder, and an increase in incubation time and chip size/number yielded no significant 
improvement over samples processed using the manufacturer’s recommendations. Over a 
third of the bones sampled resulted in a full CODIS-eligible profile from a single 50 mg 
chip with an automated workflow. Although a non-powdering extraction may not have 
been as efficient for highly compromised or low template bone samples, this method could 
be applied in a laboratory setting as a screening tool. The ability to process a smaller 
amount of bone tissue compared to many other traditional skeletal DNA extraction 
methods allows for a wider variety of skeletal elements to be tested. Interestingly, many 
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smaller bony elements frequently out-performed traditionally harvested bones for HID 
purposes regardless of the processing method used.  
In Phase 3, significantly more DNA was recovered from all bone and tooth samples 
using the PrepFiler® BTA Forensic DNA Extraction kit than the QIAamp® DNA 
Investigator® kit. However, regardless of the extraction method, consistently more alleles 
were recovered from skeletal samples with the addition of extra PCR cycles using the 
GlobalFiler® PCR Amplification Kit with minimal adverse STR artifacts. As expected, the 
improvement in STR profile quality observed with an additional PCR cycle was most 
pronounced in low template samples (<120 pg DNA). At the time of this study, no 
publications had reported the effectiveness of additional PCR cycles using the GlobalFiler® 
kit to genotype low template and/or skeletal samples. 
For the final phase of this research, sample quality flags in the Investigator® 
Quantiplex® Pro RGQ kit during DNA quantification accurately predicted STR quality in 
the majority of samples (75%) tested. The QS markers in the Investigator® 24plex QS & 
GO! kits correctly confirmed sample and/or overall STR quality in 99.9% of reference 
samples (buccal swabs and FTA® cards) and 98.4% of mock casework samples. More 
complete STR profiles were consistently obtained when samples were reworked based on 
the QS markers in conjunction with overall STR quality compared to when the EPG alone 
was used to determine sample quality and the most effective rework strategy.  
Overall, this research has demonstrated that the digestion of whole bone fragments 
may be an efficient and attractive alternative to powdering bone for DNA extraction and 
STR success may be increased in low template samples with the addition of extra PCR 
cycles using the GlobalFiler® DNA amplification kit. Additionally, this research has 
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demonstrated that Quality Sensors can aid analysts in more accurately assessing sample 
quality, and triage samples for more efficient rework strategies to improve STR success 
and avoid unnecessary reworks for ambiguous failed/low-quality STR profiles. 
Products of this work have been used as the scientific basis for changes in the 
manufacturer’s recommended protocols for STR typing of low template samples and 
influenced software updates for the analysis of STR profiles with internal quality sensors. 
Additionally, the forensic community will further benefit from the reporting of data 
exploring alternative methods for performing in-house processing, extracting and triaging 
of bone samples which will ultimately have the potential to eliminate/reduce outsourcing, 
decrease sample processing time, reduce contamination risks, and increase sample 
throughput. The various DNA workflow strategies explored throughout this research may 
facilitate an improvement in overall laboratory efficiency, leading to faster and more 
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Consent for Participation in Research 
Investigation into the benefits of the quality controls in QIAGEN’s Quantiplex and 24plex 
kits as part of the STR profiling DNA workflow 
Why am I being asked?  
You are being asked to be a participant in a research study about the forensic identification 
of forensically relevant biological samples conducted by Dr. Sheree Hughes-Stamm, the 
Department of Forensic at Sam Houston State University. You have been asked to 
participate in the research because you are eligible to participate. We ask that you read this 
form and ask any questions you may have before agreeing to be in the research.  
Your participation in this research is voluntary. Your decision whether or not to participate 
will not affect your current or future relations with Sam Houston State University or the 
Forensic Science program. If you decide to participate, you are free to withdraw at any 
time without affecting that relationship.  
Why is this research being done?  
The biological samples provided in this study will serve as mock casework evidence and 
database samples. These materials will be used for research, and will provide researchers 
with the appropriate human samples for forensic analysis investigating the utility of 
QIAGEN’s products as part of a DNA profiling workflow.  
Biological samples from living humans are required in order to simulate mock crime scene 
samples such as small amounts of blood, semen, epithelial cells, and saliva on items of 
evidence in addition to post-coital samples. The ability to recover and get a "match" from 
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the minute amounts of human DNA from these types of samples is vital for forensic 
analysis.  
What is the purpose of this research?  
The purpose of this project is to evaluate the utility of these DNA quantification and 
amplification products to identify the quantity and quality of biological source of evidence 
(saliva, semen, vaginal material, epithelial cells, and blood) in conjunction with traditional 
DNA profiling methods used for human identification.  
What procedures are involved?  
If you agree to be in this research, we may ask you to do one or more of the following 
things:  
• Wipe the inside of your cheek with two swabs for approximately 30 seconds  
• Collect saliva in a tube (approximately 1 mL).  
• Have your venous blood collected by a qualified phlebotomist (approximately 15 mL)  
• Touch various items to deposit cells from hands onto ‘touched’ evidence  
• Collect a sample of vaginal material using a cotton swab (before or after coitus) in the 
privacy in your own home.  
• Collect one emission of semen in a container in the privacy in your own home.  
Any remaining samples will be destroyed after a period of 2 years after the completion of 
the project.  
Samples will be disposed of via the standard pathological waste collection service.  





What are the potential risks and discomforts?  
There is minimal risk for the participants. These may include:  
• Mild irritation and bruising whilst getting blood drawn (arm).  
There are no significant physical or psychological, legal or reputational risks to 
participation.  
If you feel uncomfortable at any time during the study, please notify Dr. Sheree Hughes-
Stamm on 936 294 4359.  
All collection procedures will be done at the same time and no future participation is 
required.  
What other options are there?  
There are no other options. Animal samples cannot be used for forensic human 
identification work.  
What about privacy and confidentiality?  
The only person who will know that you are a research participant is the principle 
investigator (PI) of this research project. No information about you, or provided by you 
during the research will be disclosed to others without your written permission, except:  
• -if necessary to protect your rights or welfare (for example, if you are injured and need 
emergency care or when the SHSU Protection of Human Subjects monitors the research or 
consent process); or  
• -if required by law.  
When the results of the research are published or discussed in conferences, no information 
will be included that would reveal your identity. If photographs, videos, or audiotape 
recordings of you will be used for educational purposes, your identity will be protected or 
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disguised. Any information that is obtained in connection with this study and that can be 
identified with you will remain confidential and will be disclosed only with your 
permission or as required by law.  
All samples are treated as anonymous, and are assigned a numbered code upon collection. 
No personal information is collected except the sex, ancestry, hair color, eye color and skin 
color of the participant. All personal information will only be accessed by the PI.  
What if I am injured as a result of my participation?  
In the event of injury related to this research study, you should contact your physician or 
the University Health Center. However, you or your third party payer, if any, will be 
responsible for payment of this treatment. There is no compensation and/or payment for 
medical treatment from Sam Houston State University for any injury you have from 
participating in this research, except as may by required of the University by law. If you 
feel you have been injured, you may contact the researcher, Dr. Sheree Hughes-Stamm at 
936 294 4359.  
What are the costs for participating in this research?  
There are no research costs for which the subject is responsible.  
Will I be reimbursed for any of my expenses or paid for my participation in this 
research?  
The subject will not receive payment, remuneration or reimbursement for participation in 
this study.  
Can I withdraw or be removed from the study?  
You can choose whether to be in this study or not. If you volunteer to be in this study, you 
may withdraw at any time without consequences of any kind. You may also refuse to 
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answer any questions you don’t want to answer and still remain in the study. The 
investigator may withdraw you from this research if circumstances arise which warrant 
doing so.  
The participant can withdraw from this study at any time for any reason.  
Who should I contact if I have questions?  
The researcher conducting this study is Dr. Sheree Hughes-Stamm. You may ask any 
questions you have now. If you have questions later, you may contact the researchers at: 
Phone: 936 294 4359.  
What are my rights as a research subject?  
If you feel you have not been treated according to the descriptions in this form, or you have 
any questions about your rights as a research participant, you may call the Office of 
Research and Sponsored Programs –Sharla Miles at 936-294-4875 or e-mail ORSP at 
sharla_miles@shsu.edu.  
You may choose not to participate or to stop your participation in this research at any time. 
Your decision whether or not to participate will not affect your current or future relations 
with the University. Non-participation in this study will not result in any sanction.  
Participation is completely voluntary and you are under no obligation to participate. If you 
are a student, this will not affect your class standing or grades at SHSU. The investigator 
may also end your participation in the research. If this happens, your class standing or 
grades will not be affected.  
If you are a staff person at SHSU, your participation in this research is in no way a part of 
your university duties, and your refusal to participate will not in any way affect your 
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employment with the university, or the benefits, privileges, or opportunities associated with 
your employment at SHSU.  
You will not be offered or receive any special consideration if you participate in this 
research.  
Agreement to Participate  
I have read (or someone has read to me) the above information. I have been given an 
opportunity to ask questions and my questions have been answered to my satisfaction. I 
agree to participate in this research.  
Consent: I have read and understand the above information, and I willingly consent to 
participate in this study. I understand that if I should have any questions about my rights 
as a research subject, I can contact Dr. Sheree Hughes-Stamm at 936 294 4359 or by email 
at shereehs@shsu.edu. I have received a copy of this consent form.  
Your name (printed): __________________________________________________  
Signature: ______________  
Date: ___________  
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Appendix Figure B2 - Comparison of DNA concentration and STR profile results for 
Phase 1 based on incubation time for powder (n=10) and chip (n=15) samples. A) average 
DNA concentration for the high quantity samples; B) average STR profile completeness 
for the high quantity samples; C) average DNA concentration for the low-template 
samples; D) average STR profile completeness for the low-template samples. Error bars 






Appendix Figure B3 - Comparison of DNA concentration and STR profile results for 
Phase 1 based on sample type/mass and incubation time (n=5). A) average DNA 
concentration for the high quantity samples; B) average STR profile completeness for the 
high quantity samples; C) average DNA concentration for the low-template samples; D) 



















Appendix Figure B4 - DNA concentration for 20 bone chips processed in duplicate with an automated extraction in Phase 2. Values 
were normalized to the weight of the bone chip for accurate comparisons and samples are sorted by decreasing average DNA 






Appendix Figure B5 - Percentage of correct alleles called for 20 bone chips processed in duplicate with an automated extraction in 









Appendix Figure B6 - Correlation plots for the predictability of STR profile completeness based on short amplicon DNA input into 











Appendix Figure B7 - Correlation plot for the predictability of STR profile completeness based on the amount of long amplicon DNA 










Appendix Figure B8 - Comparison of secondary processing strategy STR results to the original automated extraction for each of the 









Appendix Figure B9 - Comparison of the best non-powder bone STR results to the traditional powdered bone extraction methods for 
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Appendix Table C1 - Information regarding the skeletal samples used in this study. 
 
 
Sample # Skeletal Element Insult 
1 Top Vertebral Arch Cremated 
2 Bottom Vertebral Arch Cremated 
3 Canine/Teeth Embalmed 
4 Humerus Embalmed 
5 Femur Embalmed 
6 Tibia  Decomposed body (3 weeks) 
7 Humerus Buried (24 months) 
8 Femur Buried (24 months) 
9 Femur Burned 
10 Molar Artificially degraded - boiled (4 hrs.) 
11 Molar Artificially degraded - boiled (6 hrs.) 






















Appendix Figure C1 - 3-Dimensional comparison of change in STR profile quality based 
on amount of input DNA (pg) (z-axis) and cycle number (x-axis) for (a) percentage of 
correct alleles reported; (b) average peak height; (c) average peak height ratio; (d) number 
of observed PCR artifacts (exaggerated stutter, off-ladder alleles, drop-in alleles, pull-up 






















Appendix Figure C2 - Comparison of STR success for all 30 samples when amplified using 29, 30, 31, and 32 PCR cycles. Dotted 
lines indicate the group samples are sorted into based on DNA template in PCR for data analyses. The table below (next page) indicates 






































Sample (numbered left 
to right) Input DNA (ng) 
Biological Source 
Sample  
1 0.009 2 
2 0.022 1 
3 0.026 5 
4 0.028 6 
5 0.030 9 
6 0.034 1 
7 0.035 6 
8 0.039 5 
9 0.045 5 
10 0.064 7 
11 0.073 9 
12 0.074 4 
13 0.076 7 
14 0.106 2 
15 0.116 4 
16 0.120 11 
17 0.127 10 
18 0.144 12 
19 0.163 1 
20 0.172 8 
21 0.191 11 
22 0.217 4 
23 0.231 5 
24 0.258 12 
25 0.344 3 
26 0.344 4 
27 0.413 5 
28 0.422 5 
29 0.447 2 





Appendix Table C2 - Expanded summary of all artifacts observed in STR profiles based on PCR cycle number and locus (in order 
of increasing amplicon size).  n=30. 
  29 Cycles 30 Cycles 31 Cycles 32 Cycles TOTAL 

























Y INDEL      1 1        4   6 
D2S441          1   3 5    9 
AMEL               5   5 
D22S1045 1    1    3    8 1 6 1  21 
D10S1248     2   1 3    3  10 2  21 
D3S1358 1    4    3    10  2   20 
D8S1179             7  2 3  12 
D19S433          1    1 1   3 
D5S818 1    1 1 1      10 5 7   26 
D1S1656     1    1    7     9 
vWA     1    3    2  3   9 
TH01             2  2   4 
D21S11      1       4     5 
D13S317  1    1    1  1 2 2 1   9 
D12S391 1            1  2   4 
D16S539 1    1        1     3 
D7S820     1        1  2  1 5 
FGA             1    1 2 
CSF1PO             1     1 
D18S51     1    1    6   1  9 
D2S1338     1    1    5  1   8 
TPOX                  0 
SE33        1 3    8 2  1  15 
DYS391         1    2     3 
<120 pg 0 1 0 0 2 3 1 2 3 1 0 0 19 6 1 1 1 41 
120-500 
pg 5 0 0 0 12 1 1 0 16 2 0 1 65 10 47 7 1 168 




Appendix Figure C3 - A representative electropherogram (red channel only) for one 
buried Humerus sample (0.064 ng) amplified with 29, 30, 31, and 32 cycles using the 
GlobalFiler® PCR amplification kit. Stochastic effects and other artifacts are labeled as 
follows: a) locus dropout, b) peak height imbalance, c) allele dropout, d) exaggerated 















Appendix Figure D1 – Direct amplification workflow used in this study for processing 
cotton and Bode buccal swabs. Swabs stored at room temperature were used as controls 






Appendix Figure D2 – Direct amplification workflow used in this study for processing 
saliva and blood samples on FTA® cards. FTA® cards stored at room temperature were 
used as controls and insult categories included: storage in hot and humid conditions, UV-
exposure (saliva only), and low blood volume samples (blood only) processed with and 


















Appendix Figure D4 – Comparison of reportable alleles over time for each substrate type after incubating samples in a hot and humid 
environment. Substrates include: cotton buccal swabs (top left), Bode buccal swabs (top right), FTA® saliva cards (bottom left), and 







Appendix Figure D5 – Comparison of STR profile quality metrics (average peak heights – primary Y-axis; average peak height ratios 
– secondary Y-axis) over time for each substrate type after incubating samples in a hot and humid environment. Substrates include: 
cotton buccal swabs (top left), Bode buccal swabs (top right), FTA® saliva cards (bottom left), and FTA® blood cards (bottom right). 







Appendix Figure D6 – Comparison of reportable alleles between different exposure times to direct UV light for each substrate type. 
Substrates and exposure times include: Bode buccal swabs – 2.5-15 mins (top left), cotton buccal swabs – 6-24 hrs (top right), and FTA® 







Appendix Figure D7 – Comparison of STR profile quality metrics (average peak heights – primary Y-axis; average peak height ratios 
– secondary Y-axis) between different exposure times to direct UV light for each substrate type. Substrates and exposure times include: 







Appendix Figure D8 – Example of a full profile sample with an S/Q ratio below 20%. Left - EPG of sample after original CE injection 







Appendix Figure D9 – Comparison of reportable alleles between three concentrations of each inhibitor tested in this study. Inhibitors 
and their concentration ranges include: melanin (25-60 ng/µL), humic acid (100-400 µM), hematin (500-1500 ng/µL), and 70% ethanol 







Appendix Figure D10 – Average male DNA concentrations (n=4) recovered in the sperm fractions of mock sexual assault samples for 






Appendix Figure D11 – Male DNA concentrations recovered in the sperm fractions of authentic post-coital samples for each collection 









Appendix Figure D12 - Example of an EPG showing a mixture (top) that was not flagged during qPCR (bottom) as determined by a 
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The Investigator® 24plex GO! and Investigator® 24plex QS kits are 6-dye multiplex 
assays for the identification of human reference and casework samples, respectively. In 
addition to the expanded CODIS core and three additional autosomal loci (SE33, D2S1338 
and D19S433), these kits also include two quality sensor targets (QS1 and QS2) that serve 
as internal PCR controls. The presence, absence or relative amplification of these quality 
sensors can assist the interpretation of STR profiles and direct analysts toward more 
effective rework strategies (1). 
The use of direct PCR for database and reference samples has greatly increased 
laboratory throughput by employing automated solutions and bypassing the time-
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consuming and costly DNA extraction and quantification processes. Due to the predictable 
nature of databasing samples (buccal swabs and FTA® cards), full STR profiles can be 
generated from a majority of them. However, lack of purification can leave some samples 
vulnerable to PCR inhibition, while other complicating factors, such as DNA degradation 
and low amounts of DNA (LT-DNA), can also affect downstream STR success (1–5). 
Sources of inhibition can originate from the collection/preservation method used or the 
sample itself. The main sources of PCR inhibitors in reference blood samples include 
endogenous hematin and EDTA from blood collection tubes and FTA cards (6). DNA 
degradation may occur in samples stored improperly or in a facility with limited climate 
control. For buccal swabs, poor collection   and storage techniques as well as exogenous 
inhibitors from food and beverages can produce low template and/or inhibited profiles (7). 
In this study we selected a set of challenging samples (N=53) that generated less 
than 90% reported alleles in the first amplification round. To assess the values of the QS 
markers included in the STR kits, the samples were then reworked based on the quality of 
the electropherogram (EPG) with the QS markers redacted (Figure 1A) and in conjunction 
with the QS markers (Figure 1B). Results from each of the reworks were analyzed to 






Sample collection and preparation 
Databasing samples 
Reference DNA samples were collected from informed and consenting participants 
pursuant to IRB 2018-05-40949 approved by Sam Houston State University. A subset of 
samples (N=53) from a larger sample pool were chosen for this study based on STR profile 
completeness. Blood samples were collected via venipuncture and spotted on Whatman® 
FTA cards (GE Healthcare). Saliva samples were collected using sterile cotton tipped 
applicators (Puritan Medical Products Company), the Bode Buccal DNA Collector® 
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system (Bode Technology) or Whatman FTA cards with Easicollect™ devices (GE 
Healthcare) using manufacturers’ recommended protocols (hereafter referred to as cotton 
swabs, Bode swabs and saliva FTA samples, respectively). 
With the exception of room temperature controls, databasing samples were 
subjected to a variety of simulated environmental conditions, including incubation in a hot 
and humid environment for  up to 27 weeks, UV exposure for between 1 minute and 24 
hours, and poor collection methods, such as single cheek swipes for buccal swabs. Low 
blood volume samples were simulated using purple-topped blood collection tubes with less 
than 0.75 ml of blood. Blood from the collection tubes was then deposited onto FTA cards. 
Casework-like samples 
DNA extracts previously identified as inhibited, low-template or degraded were 
used in this study. Inhibited and degraded samples were sourced from cadaver muscle 
biopsies stored in a liquid preservative and unpreserved nylon swabs. In addition, samples 
spiked with inhibitors (hematin, melanin, humic acid and ethanol) were prepared using neat 
inhibitors and control DNA. 
DNA quantification and amplification 
Setup for all quantification and amplification reactions was performed using a 
QIAGEN QIAgility® liquid handling platform. All mock casework samples were 
quantified using the Investigator Quantiplex® Pro RGQ kit on a QIAGEN Rotor-Gene® Q 
and results were analyzed with the QIAGEN Data Handling Tool. 
Databasing samples were amplified using the QIAGEN Investigator 24plex GO! 
chemistry. DNA in both cotton and Bode swabs was amplified according to the 
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manufacturer’s guidelines using 26 PCR cycles. For both saliva and blood FTA cards, 
single 1.2 mm punches were manually deposited into the wells of a 0.2 ml 96-well plate 
and 20 µl of STR GO! lysis buffer was directly added to the punches. The plate was then 
centrifuged and incubated at 95°C for 5 minutes before 2 µl of the crude lysate was added 
to 20 µl GO! Master Mix. Additionally, a subset of blood FTA samples were directly 
amplified without use of the GO! lysis buffer. DNA in FTA blood and saliva samples was 
amplified for 27 PCR cycles. 
All sample dilutions for mock casework samples targeted a final DNA input per 
reaction of 0.8 ng. Samples were amplified with the QIAGEN Investigator 24plex QS Kit 
according to the manufacturer’s protocol on either a ProFlex™ (Applied Biosystems) or 
Veriti™ (Applied Biosystems) thermal cycler. 
Capillary electrophoresis and data analysis 
Amplified fragments were separated and detected on an Applied Biosystems® 3500 
Genetic Analyzer on a 36 cm capillary array using handbook-defined settings. Data 
analysis was completed using GeneMapper IDX v1.4 with tertiary analysis being 
accomplished with in-house Excel® (Microsoft Corp.) workbooks. Stochastic and 
analytical thresholds were set at 200 RFU and 100 RFU, respectively. 
Sample reworks 
Strategy determination 
To assess the benefits of the QS markers present in STR profiles, strategies for 
reworking samples were determined by analyzing STR profiles with and without the QS 
marker information visible. To avoid bias, a forensic DNA analyst from an external crime 
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laboratory was asked to interpret EPGs with the QS markers redacted. For databasing 
samples, the analyst was provided with the sample type (blood vs buccal) and substrate 
(FTA card vs Bode/cotton swab) and asked to indicate their rework strategy. Quantification 
information was also provided to the analyst during STR profile evaluation for casework 
samples, as these data would normally be available regardless of the STR chemistry used. 
The analyst used their experience and their laboratory’s standard operating procedures 
(SOPs) to assess the profile quality and determine the appropriate rework strategy (if any). 
In addition to the rework approach indicated by the external analyst (blinded to QS 
markers), samples were also examined by a different analyst who indicated their rework 
strategy based on the performance of the QS markers. With the QS marker information, 
inhibition was suspected when the Quality Sensor S/Q allele ratio was below 70% and 
confirmed when one or both QS markers dropped out. Samples were classified as low 
template and/or degraded when the QS markers were balanced and low RFUs were 
observed consistently throughout the EPG (roughly average peak height of <750 RFUs). 
The absence of DNA template in the PCR was determined by the presence of balanced QS 
markers and no other alleles called. In general, rework strategies were determined as 
follows: adding more template to the PCR amplification (for suspected low or degraded 
template), diluting the lysate/extract before re-amplifying (for suspected PCR inhibition), 
or processing a new punch from the same sample (for suspected failed amplification due 
to no template). 
Strategy implementation 
Rework strategies for each sample were designated, executed and compared. If the 
strategies with and without the QS markers were the same, the rework was only performed 
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once. Databasing samples requiring an increased template included either an additional 
microliter of lysate (3 µl total) if available or two 1.2 mm punches added to the PCR. For 
samples identified as inhibited, either a 1:3 dilution or a punch wash with GO! lysis buffer 
was performed before re-amplification. Inhibited casework samples were diluted as much 
as 1:15 and re-quantified prior to re-amplification. Finally, samples categorized as having 
no DNA template in the PCR were reprocessed either as a new punch or from the original 
lysate/extract when applicable. All PCR cycling conditions and CE parameters remained 
the same as for the initial amplification. 
Results and Discussion 
As expected, reworking challenging samples resulted in more complete STR 
profiles compared to the original amplifications (Figure 2). Compared to the inhibited 
samples, the degraded/low template samples produced more complete STR profiles but 
also yielded wider variations in first- pass amplification success rates. Overall, the increase 
in allele recovery after applying both rework strategies was comparable for degraded/low 
template samples but differed for those that were inhibited (Figure 2). The greatest 
improvement in STR success was achieved when inhibited samples were reworked based 
on information provided by the QS markers (29/29 samples improved) rather than relying 
on the quality of the EPG alone (20/29 samples improved; Figure 2). Although a   trained 
analyst may be able to identify signs of PCR inhibition within the profile, this study found 





Interestingly, direct amplification of several low blood volume FTA cards resulted 
in complete amplification failure. We suspect that the accumulation of EDTA in these 
samples from both the blood tubes and the unwashed FTA cards resulted in high levels of 
PCR inhibition. Without the QS marker information, the external analyst assumed the 
punch contained no DNA template and the rework strategy was to process a new punch, 
which yielded the same results as the initial assays (Figures 1A and 1B). However, with 
the QS marker information available, inhibition was indicated due to one or both QS 
markers failing to amplify, and the appropriate rework strategy was identified. In these 
cases, a wash with GO! lysis buffer was performed and full STR profiles were recovered 
(Figure 1C). 
For samples that had concordant rework strategies regardless of the QS markers, an 
increase in correct alleles called was achieved 94% of the time. It is important to note that 
although the rework strategies were identical, the QS markers did provide the analyst with 
high confidence regarding the level of DNA degradation in the samples. One sample that 
showed no improvement after rework was highly degraded/low template, and therefore the 
maximum amount of template was already being amplified. Another sample still showed 
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signs of extreme inhibition after several dilution attempts, which was confirmed by the QS 
marker information. 
Of the 53 samples reworked, 20 were identified as having different rework 
strategies based on the characteristics of the DNA profile provided to the analysts, either 
with or without the QS markers being masked. This demonstrates that although 
experienced analysts are frequently able to correctly identify the likely cause of a loss of 
alleles or overall poor profile quality, there are still circumstances where the true issue may 
be more ambiguous. When the QS markers were used to assess the likely cause of a poor 
STR result, the reason for PCR failure could be readily identified and the correct rework 
strategy employed (Figure 3). The QS markers were most beneficial in resolving failed 
amplifications and highly inhibited samples (Figure 4). The rework strategy based on the 
QS markers resulted in all but two of those 20 samples having full or nearly full STR 







In addition to recovering more loci, rework strategies based on QS marker 
information also resulted in improvements in general profile quality. Profile quality of the 
first amplification was poor,  and only 3.2% of samples showed an average peak height 
ratio (APHR) above 60% and only 13.2% of samples had an average peak height (APH) 
above 200 RFUs (stochastic threshold). In comparison, 32% of reworks without the QS 
markers and 47% samples with QS markers showed an APHR above 60%. Also, 47% of 
samples without QS markers and 55% of samples with QS markers had an APH above 200 
RFUs (Figure 5). Overall, when QS markers were used to determine the rework strategy, 
consistently more alleles were recovered and a greater number of samples with balanced, 





Most forensic DNA analysts are able to distinguish between degraded, low template 
and inhibited STR profiles after adequate training and experience. However, there are 
many instances when the best approach for how to rework a particular sample to improve 
results may not be apparent. This study demonstrates that QS markers can be used as a 
straightforward, consistent and valuable tool to assist in the interpretation of STR profiles 
from challenging samples. The ability to distinguish between highly inhibited samples, 
severely degraded DNA and failed amplification informs the analyst on the most 
appropriate rework strategy to eliminate or minimize the number of reworks performed, 
saving both time and resources, which ultimately improves overall efficiency. 
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